| Apr 26, 2006 |
Washington Business Journal: MedImmune to invest in N.J. biotech |
|
|
| Apr 26, 2006 |
Washington Post: Drug Firms' Deals Allowing Exclusivity |
|
|
| Apr 26, 2006 |
Medical-News.net: Protein mutated in cancer found to be linked to diabetes |
|
|
| Apr 26, 2006 |
KGBT-TV (TX): Study suggests money influences federal drug advisory panel voting |
|
|
| Apr 26, 2006 |
Industry Week: St. Louis: Gateway For New Medicines |
|
|
| Apr 26, 2006 |
The Age (Australia): Warning on reining in health care costs |
|
|
| Apr 26, 2006 |
Trading Markets: Wyeth Issues Statement On Petition Filed With FDA Related To Bio-identical Hormone Replacement Therapies |
|
|
| Apr 24, 2006 |
CBS News: Report: Drug Oversight Needs Work |
|
|
| Apr 17, 2006 |
West Central Tribune (MN): Addressing pharmacist shortage through innovation |
|
|
| Apr 17, 2006 |
The Age: Biotechnology 2006: there could be a fly in the ointment in Chicago |
|
|
| Apr 17, 2006 |
Press Release: New York's Biotechnology Sector Gains Momentum |
|
|
| Apr 17, 2006 |
Science & Technology News: Biotechnology thrives in India |
|
|
| Apr 17, 2006 |
DailyTech: Biotechnology Scientists Going Abroad in Search of Work |
|
|
| Apr 12, 2006 |
Austin Daily Herald (MN): Gaining access to cheaper prescriptions |
|
|
| Apr 12, 2006 |
Medical News Today: Are Pharmaceutical Companies Inventing Diseases, New Study Suggests They Are |
|
|
| Apr 12, 2006 |
Press Release: Product Re-Launch: Transforming Lackluster Pharmaceutical Products Into Market Success Stories |
|
|
| Apr 12, 2006 |
TradingMarkets.com: Teva Pharmaceutical Says FDA Denies Apotex's Request For Agency Determination For Pravastatin |
|
|
| Apr 12, 2006 |
The Independent (UK): Pharmaceutical groups defend record on drug prices for NHS |
|
|
| Apr 12, 2006 |
Chicago Sun-Times (IL): Biotechnology touted at Chicago conference |
|
|
| Apr 11, 2006 |
TradingMarkets.com: American Pharmaceutical Partners Gets FDA Approval For Its ANDA For Mitoxantrone Injection, USP |
|
|
| Apr 10, 2006 |
MercuryNews.com (MN): Stroke remedy showing promise |
|
|
| Apr 10, 2006 |
Business Week: Sanofi Aventis buys land for new facility |
|
|
| Apr 10, 2006 |
CNN: FDA backlog = Billions for Big Pharma? |
|
|
| Apr 10, 2006 |
Smartmoney.com: Serono Cancels Buyer Search, Eyes Deals |
|
|
| Apr 10, 2006 |
9News.com (CO): AARP: Brand-name drug prices shot past inflation |
|
|
| Apr 10, 2006 |
Bloomberg: Parexel Misled People Sickened by Test, Ethicists Say |
|
|
| Apr 10, 2006 |
ComputerWorld: Pharmaceutical company standardizes CRM |
|
|
| Mar 20, 2006 |
Press Release: TargetRx Unveils First Industry Analysis Linking Pharmaceutical Sales Force Effectiveness with Physician Prescribing |
|
|
| Mar 20, 2006 |
East Bay Business Times (CA): Viper's venom may help Emeryville biotech treat stroke |
|
|
| Mar 18, 2006 |
Pharmaceutical Manufacturing: MTC's Rich Kneece Featured in Pharma Manufacturing 2006 Job & Salary Survey |
|
|
| Feb 15, 2006 |
Press Release: Pharma Companies Look to R&D Operations in China to Secure a Future in the Chinese Health Care Market |
|
|
| Feb 15, 2006 |
Press Release: Biolex Therapeutics Presents Results Highlighting Benefits of Locteron at 'Breakthroughs in Hepatitis' Session |
|
|
| Feb 15, 2006 |
Press Release: New Targeted Treatment for Brain Tumors Shows Promise in Pre-Clinical Models |
|
|
| Feb 15, 2006 |
Press Release: Callisto's Cancer Drug Atiprimod to be Presented at Major Scientific Conference on Angiogenesis |
|
|
| Feb 15, 2006 |
Business Week: Genzyme swings to 4Q profit on less R&D |
|
|
| Feb 15, 2006 |
Palm Beach Post (FL): Web site to train new biotech workers |
|
|
| Jan 6, 2006 |
Boston Business Journal (MA): Repligen sues Bristol-Myers Squibb over drug patent |
|
|
| Jan 6, 2006 |
Press Release: Pfizer Introduces Radio Frequency Identification Technology to Combat Counterfeiting, Protect Patient Health |
|
|
| Jan 6, 2006 |
Press Release: Nobelist Discovers Antidepressant Protein in Mouse Brain |
|
|
| Jan 6, 2006 |
Press Release: Enzon Pharmceuticals to Return Rights to ATG-Fresenius S |
|
|
| Jan 6, 2006 |
MSNBC: Rhodia sells drugs unit to Shasun |
|
|
| Jan 6, 2006 |
Genetic Engineering News: A Company Review of Merck & Co, Covering, for Example, Their Current Status and Future Outlook |
|
|
| Dec 28, 2005 |
Press Release: Pfizer Takes 12% of Perlegen Sciences |
|
|
| Dec 28, 2005 |
Press Release: Targanta Acquires Late-Stage Antibiotic from InterMune |
|
|
| Dec 28, 2005 |
Smartmoney.com: Celgene Wins FDA Approval for Revlimid |
|
|
| Dec 28, 2005 |
News.com (Australia): Two top stem cell researchers lured to US |
|
|
| Dec 28, 2005 |
Forbes: Genentech on Forbes' Platinum list |
|
|
| Dec 28, 2005 |
MSNBC: AstraZeneca, Reloaded |
|
|
| Dec 28, 2005 |
Post-Gazette (PA): As biotech drug prices rise, U.S. hunts for solution |
|
|
| Dec 13, 2005 |
NY Newsday (NY): Voyager Pharmaceutical Withdraws IPO |
|
|
| Dec 13, 2005 |
Press Release: Allergan Welcomes Inamed's Recommendation of Its Offer to Stockholders |
|
|
| Dec 13, 2005 |
Press Release: NIH Launches Comprehensive Effort to Explore Cancer Genomics |
|
|
| Dec 13, 2005 |
Press Release: Diamyd Medical broadens diabetes pipeline with acquisition of Nurel Therapeutics |
|
|
| Dec 13, 2005 |
Press Release: Genzyme Uses Job Scheduler to Streamline BI for Financial Reporting |
|
|
| Dec 13, 2005 |
Associated Press: Palm Beach commissioners to examine Scripps split-campus plan |
|
|
| Nov 30, 2005 |
Press Release: GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology and Supportive Care Compounds |
|
|
| Nov 26, 2005 |
Press Release: Depomed Announces Non-Binding Term Sheet Agreement With Biovail for Glumetza |
|
|
| Nov 26, 2005 |
Press Release: FDA Issues Approvable Letter For EPIX Pharmaceuticals Blood-Pool Contrast Agent Vasovist(TM); US Regulators Want Another Trial |
|
|
| Nov 26, 2005 |
Press Release: Jazz Pharmaceuticals, Inc. Release: Xyrem(R) Receives FDA Approval For The Treatment Of Excessive Daytime Sleepiness In Patients With Narcolepsy |
|
|
| Nov 26, 2005 |
Press Release: Tripos Gets $90 Million From Pfizer Inc. Collaboration |
|
|
| Nov 26, 2005 |
Press Release: Alexion Pharmaceuticals Inc. Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations |
|
|
| Nov 15, 2005 |
Press Release: Pfizer Inc.'s Torcetrapib/Atorvastatin Significantly Raised "Good" Cholesterol While Lowering "Bad" Cholesterol, New Data Show |
|
|
| Nov 15, 2005 |
Press Release: Celgene Receives Approvable Letter From FDA For THALOMID(R) In Treatment Of Newly Diagnosed Multiple Myeloma |
|
|
| Nov 15, 2005 |
Press Release: COPAXONE(R) Demonstrated Protection Against Neuronal Injury in Relapsing-Remitting Multiple Sclerosis |
|
|
| Nov 15, 2005 |
Press Release: Cerexa to Present at Credit Suisse First Boston Healthcare Conference |
|
|
| Nov 15, 2005 |
Press Release: PharmaFrontiers Reports Third Quarter 2005 Financial Results; Provides Update on Research & Development Activities |
|
|
| Nov 15, 2005 |
Press Release: MediGene's Drug Eligard Launched in Spain and Further European Countries |
|
|
| Nov 10, 2005 |
Press Release: Seizing the US Pharma Market: A Brand's Battle to the Top |
|
|
| Nov 10, 2005 |
Press Release: Ranbaxy wins on Atorvastatin process patent in Norway – Will appeal court ruling on intermediate compound patent |
|
|
| Nov 10, 2005 |
Press Release: Dynavax's TOLAMBA(TM) Demonstrates Safety in Phase 1 Trial of Ragweed Allergic Children |
|
|
| Nov 10, 2005 |
Press Release: Achieving Market Success: Thought Leaders Drive Success from Early Stage to Post-Launch |
|
|
| Nov 3, 2005 |
Press Release: Angiotech Pharmaceuticals (ANPI) Buys Graft Business For C$14 Million |
|
|
| Nov 3, 2005 |
Press Release: Celgene Corporation (CELG) Release: Clinical Data On Thalidomide Reported In Recurrent Epithelial Ovarian Cancer |
|
|
| Nov 3, 2005 |
Press Release: Court Denies Pfizer Inc.'s Summary Judgment Motion In Amlodipine Litigation With Mylan Pharmaceuticals, Inc. |
|
|
| Nov 3, 2005 |
Press Release: Investigator Presents Update on Phase III Nexavar(R) Trial in Patients with Advanced Kidney Cancer |
|
|
| Nov 3, 2005 |
Press Release: Merck Wins New Jersey VIOXX(R) Product Liability Case |
|
|
| Nov 3, 2005 |
Press Release: Abgenix And Amgen Announce Panitumumab Significantly Improves Progression-Free Survival In Phase 3 Randomized Metastatic Colorectal Cancer Study |
|
|
| Nov 3, 2005 |
Press Release: Novarits Exjade(R) Receives First Approval Worldwide In The U.S. |
|
|
| Nov 3, 2005 |
Press Release: Tarceva Now Approved for Advanced Non-Small Cell Lung Cancer and Pancreatic Cancer |
|
|
| Nov 3, 2005 |
Press Release: Biolex Therapeutics Announces Initiation of Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM) |
|
|
| Nov 3, 2005 |
Press Release: Enzon Reports First Quarter Results |
|
|
| Nov 3, 2005 |
Press Release: Ranbaxy Granted Permission to Appeal U.K. High Court Judgement on Patent Relating to Atorvastatin |
|
|
| Nov 3, 2005 |
Press Release: OPi receives marketing authorisation for Xenazine® 25 mg in France |
|
|
| Nov 3, 2005 |
Press Release: Biotech 2006 Set for May 22-23 in Winston-Salem |
|
|
| Nov 3, 2005 |
Press Release: Curis to Present at CIBC World Markets 16th Annual Healthcare Conference |
|
|
| Nov 3, 2005 |
Press Release: SeraCare Life Sciences to Present at the 16th Annual CIBC Healthcare Conference |
|
|
| Nov 3, 2005 |
Press Release: Medicure To Present At Biotech Investor Conference |
|
|
| Oct 28, 2005 |
Press Release: Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile |
|
|
| Oct 26, 2005 |
Press Release: Tanox, Inc. (TNOX) Reports Positive Results From Phase 2 Clinical Trial Of TNX-355, An Entry Inhibitor To Treat HIV |
|
|
| Oct 26, 2005 |
Press Release: Johnson & Johnson (JNJ) To Co-Develop Bayer Corporation (BAY)'s Key Thrombosis Drug |
|
|
| Oct 26, 2005 |
Press Release: Cerimon Pharmaceuticals Raises $70 Million In Series A Financing |
|
|
| Oct 26, 2005 |
Press Release: OXiGENE reports third-quarter 2005 operational and financial results |
|
|
| Oct 26, 2005 |
PR Newswire: Biolex Therapeutics Successfully Completes Phase 1 Study for First LEX System (TM) Produced Therapeutic Protein |
|
|
| Oct 18, 2005 |
Press Release: Bristol-Myers Squibb Company And Merck & Co., Inc. Say FDA Seeks More Data On Pargluva |
|
|
| Oct 18, 2005 |
Press Release: Genentech, Inc. Says Tarceva Doesn't Boost Avastin Effect |
|
|
| Oct 18, 2005 |
Press Release: GlaxoSmithKline's Havrix(R) (hepatitis A vaccine, inactivated) Now Approved For Use in Children Aged 12 Months and Older |
|
|
| Oct 18, 2005 |
Press Release: Novo Nordisk begins phase 1 study with rFXIII in cardiac surgery |
|
|
| Oct 18, 2005 |
Press Release: Galapagos Expands Its Collaboration with Serono |
|
|
| Oct 18, 2005 |
Press Release: Swedish Drug Development Company OxyPharma Starts Phase I Studies for RA Drug |
|
|
| Oct 18, 2005 |
Press Release: MediGene Honored with European Biotechnica Award |
|
|
| Oct 13, 2005 |
Press Release: Array BioPharma, Inc. (ARRY) And Genentech, Inc. (DNA) Expand Strategic Oncology Collaboration |
|
|
| Oct 13, 2005 |
Press Release: TRANSGENE Signs Agreement For The Production Of Innogenetics' Hepatitis B Therapeutic Vaccine Candidate |
|
|
| Oct 13, 2005 |
Press Release: Inspire Provides Update on Cystic Fibrosis Program; Moving Forward to Request End-of-Phase 2 Meeting with FDA |
|
|
| Oct 13, 2005 |
Press Release: Access Pharmaceuticals Restructures To Focus On Oncology Therapeutics; Oral Care Business Sold |
|
|
| Oct 12, 2005 |
Press Release: Area Life Science Companies Chosen to Make Presentations for Venture Funding at 2005 Mid-Atlantic Bio |
|
|
| Oct 12, 2005 |
Press Release: West Nile Vaccine Licensed by Hawaii Biotech |
|
|
| Oct 12, 2005 |
Press Release: Lilly ICOS Announces Positive Results from Phase 2 Study of Tadalafil in Treating Symptoms of Benign Prostatic Hyperplasia |
|
|
| Oct 11, 2005 |
Press Release: Accredo Health Inc. Announces Agreement To Acquire Specialty Pharmacy Business For Approximately $72 Million |
|
|
| Oct 11, 2005 |
Press Release: Alpharma Inc. Receives FDA Clearance To Initiate Phase II Clinical Trials For Abuse-Resistant, Extended-Release Opioid |
|
|
| Oct 11, 2005 |
Press Release: Antigenics Jumps On Phase 3 Melanoma Drug Data |
|
|
| Oct 11, 2005 |
Press Release: Praxis Recruitment Campaign Enrolls Rheumatoid Arthritis Study Two Months Early |
|
|
| Oct 10, 2005 |
Press Release: Genzyme licenses technology from UCLA and JNJ's Remicade Gets Expanded EU Approval |
|
|
| Oct 10, 2005 |
Press Release: Innate Pharma completes its management team with the recruitment of Dr. Patrick Squiban as Chief Medical Officer |
|
|
| Oct 10, 2005 |
Press Release: iCell Therapeutics Receives Support From the National Research Council's Industrial Research Assistance Program for Development of Cancer Treatment |
|
|
| Oct 10, 2005 |
Press Release: VIRA 38 Fraction (v38 AMF-1) Inhibits Bird Flu Virus (H5N1) Infections by Blocking Viral Attachment |
|
|
| Oct 10, 2005 |
Press Release: Agensys Signs Collaborative Research and License Agreement With sanofi pasteur |
|
|
| Oct 5, 2005 |
Press Release: North Carolina Biotechnology Center to dedicate new offices in Wilmington, Greenville |
|
|
| Oct 5, 2005 |
Press Release: Cambridge Antibody Technology Reports Recent Progress In Licensed Product Candidates |
|
|
| Oct 5, 2005 |
Press Release: Rib-X Granted Key Antibiotic Drug Discovery Patents |
|
|
| Oct 5, 2005 |
Press Release: Chemokine Therapeutics expands protection of core anti-cancer technology with issuance of new U.S. patent |
|
|
| Oct 5, 2005 |
Press Release: Shorter Course of PEG-INTRON(R) and REBETOL(R) Combination Therapy Approved in EU |
|
|
| Oct 5, 2005 |
Press Release: Provectus to Begin Clinical Trial on Breast Cancer |
|
|
| Oct 5, 2005 |
Press Release: Genzyme expands its research and manufacturing presence in Massachusetts |
|
|
| Oct 5, 2005 |
Press Release: USC Marshall School of Business to present European BioBusiness Leadership Award 2005 at CORDIA |
|
|
| Oct 5, 2005 |
Press Release: Bernard Siegel Receives 2005 Stem Cell Advocacy Award |
|
|
| Sep 29, 2005 |
Press Release: Pharming Expands Clinical Development Of Recombinant Human C1 Inhibitor For New Indications |
|
|
| Sep 29, 2005 |
Press Release: Active Biotech Presents Survival Data on Cancer Drug |
|
|
| Sep 29, 2005 |
PR Newswire: Provid Announces New National Cancer Institute Contract |
|
|
| Sep 29, 2005 |
Washington Post (DC): FDA Chief Wants Transformation in Medicine |
|
|
| Sep 29, 2005 |
Boston Globe (MA): FDA chief's resignation comes as surprise |
|
|
| Sep 29, 2005 |
Bio-IT World: Weekly IT and Informatics Product Roundup |
|
|
| Sep 29, 2005 |
Bio-IT World: FDA’s Gottlieb Blasts Importation and Calls for New Technology |
|
|
| Sep 27, 2005 |
Press Release: FDA Approves Pfizer's Lipitor(R) to Reduce Risk of Strokes and Heart Attacks in Patients With Diabetes |
|
|
| Sep 27, 2005 |
Press Release: RxHub Advances Electronic Prescribing Through Its Standards Approved By NCPDP and Its Partnership With Industry Leaders |
|
|
| Sep 27, 2005 |
Press Release: DOV Pharmaceutical, Inc. Announces Phase II Efficacy Results for One of its Novel Antidepressants, DOV 216,303 |
|
|
| Sep 27, 2005 |
Press Release: CuraGen and TopoTarget Initiate Phase Ib Clinical Trial with PXD101 for Advanced Colorectal Cancer |
|
|
| Sep 27, 2005 |
Press Release: PhRMA President Billy Tauzin Applauds Appointment of FDA Acting Commissioner |
|
|
| Sep 27, 2005 |
Press Release: Invitrogen to Present at UBS Global Life Sciences Conference |
|
|
| Sep 27, 2005 |
Press Release: Manhattan Research Reveals the Top 5 Traits of the 'Ideal' eDetail |
|
|
| Sep 27, 2005 |
Press Release: Biogen Idec and Elan Submit Supplemental Biologics License Application to the FDA for TYSABRI |
|
|
| Sep 23, 2005 |
Press Release: Vernalis signs new agreement with Diosynth Biotechnology for Phase III clinical trials |
|
|
| Sep 23, 2005 |
Press Release: Genzyme Opens New Discovery Research and Development Facility in Cambridge and Expands Manufacturing Site in Haverhill, UK |
|
|
| Sep 23, 2005 |
Press Release: Fisher Scientific to Present at UBS Global Life Sciences Conference |
|
|
| Sep 21, 2005 |
Chemical & Engineering News: Pharma, A Bright Spot In Hiring |
|
|
| Sep 19, 2005 |
Press Release: Parkinson's Patient Advocates Call on Amgen to Move Forward with GDNF Clinical Trials |
|
|
| Sep 19, 2005 |
Press Release: Viventia Receives FDA Clearance to Initiate Phase II Cancer Trial for Proxinium |
|
|
| Sep 19, 2005 |
Press Release: New Life Scientific signs Letter of Intent with CureLab, Inc. for long term agreement of Joint Development and Marketing Plan |
|
|
| Sep 19, 2005 |
Press Release: N.C. Bio Pharma Business Development Group changes name, expands reach |
|
|
| Sep 19, 2005 |
Press Release: Genentech Announces October 10 Webcast Discussion of Earnings and Other Business Results |
|
|
| Sep 15, 2005 |
Press Release: Missouri Governor Honored With Significant National Biotech Award |
|
|
| Sep 15, 2005 |
Press Release: PRA International Announces Partnership with Biomira Inc. |
|
|
| Sep 15, 2005 |
Press Release: FDA Commissioner Dr. Lester Crawford to Deliver Keynote Address at the Seventh Annual MASS Opportunities Biotechnology Investment Conference |
|
|
| Sep 15, 2005 |
Press Release: BioProcessors’ SimCell Platform Selected by Novo Nordisk |
|
|
| Sep 15, 2005 |
Press Release: Overcoming Adoption Challenges for Pharma Industry Highlighted at Patient-Level Data Conference |
|
|
| Sep 12, 2005 |
Press Release: Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin |
|
|
| Sep 12, 2005 |
PR Newswire: Peptides and Therapeutic Proteins Emerging as Attractive Drug Targets for the Pharmaceuticals Industry |
|
|
| Sep 12, 2005 |
Business Wire: SCOLR Pharma, Inc. Issued Second Patent for Platform Used to Formulate Challenging Drugs |
|
|
| Sep 7, 2005 |
Press Release: Protein Design Labs Phase 2 Ularitide Study Highlighted At European Society of Cardiology Congress |
|
|
| Sep 7, 2005 |
Press Release: AMBIEN CR(TM) CIV Receives FDA Approval For The Treatment Of Insomnia |
|
|
| Sep 7, 2005 |
Press Release: FDA Approves Vaccine to Help Protect Children Against Measles, Mumps, Rubella and Chickenpox in One Shot |
|
|
| Sep 7, 2005 |
Business Wire: Andrx Reports on FDA Developments |
|
|
| Sep 7, 2005 |
Business Wire: Chiron Responds to Novartis Offer |
|
|
| Sep 2, 2005 |
Press Release: Approvable Letter Received from the FDA for Dacogen(TM) (Decitabine) Injection for the Treatment of MDS |
|
|
| Aug 31, 2005 |
Press Release: Cost-effective R&D Outsourcing Attracts Global Pharmaceutical Industry to India and China |
|
|
| Aug 31, 2005 |
Press Release: Patient Recruitment Plays a Major Role in Meeting Clinical Trial Deadlines |
|
|
| Aug 31, 2005 |
Press Release: FDA Approves Tercica's Increlex for Short Stature Caused by Severe Primary IGF-1 Deficiency |
|
|
| Aug 31, 2005 |
Press Release: ImmunoGen, Inc. Announces that the sanofi-aventis Group Has Extended its Research Collaboration with the Company |
|
|
| Aug 29, 2005 |
Press Release: Par Pharmaceutical Receives Final Approval to Market Generic Questran(R) Powder and Questran(R) Light Powder for Oral Suspension |
|
|
| Aug 29, 2005 |
Press Release: California Attorney General Accuses Drug Companies of Fraud |
|
|
| Aug 29, 2005 |
Press Release: Invitrogen Signs Agreement with Nonlinear Dynamics to Distribute Advanced Analysis Software Solutions |
|
|
| Aug 26, 2005 |
Press Release: FDA Defers Decision on Plan B Over-the-Counter Application |
|
|
| Aug 26, 2005 |
Press Release: Encore Pharmaceuticals Receives Second 2005 SBIR Award |
|
|
| Aug 26, 2005 |
Press Release: DRAXIS Extends Scheduled Shutdown for Contract Manufacturing Division |
|
|
| Aug 26, 2005 |
Press Release: Pfizer expands SUTENT® (sunitinib malate) access program to patients with kidney cancer |
|
|
| Aug 24, 2005 |
Press Release: Amexdrug Corporation to Acquire Dermagen, Inc. |
|
|
| Aug 24, 2005 |
Press Release: Isis Pharmaceuticals Raises $51 Million in Private Offering |
|
|
| Aug 24, 2005 |
Press Release: Bioinformatics Market Surges Ahead |
|
|
| Aug 24, 2005 |
Press Release: Icoria to Conduct Biomarker Study for Isis Pharmaceuticals |
|
|
| Aug 24, 2005 |
Press Release: Eric Brandt to Be President and Chief Executive Officer of AVANIR Pharmaceuticals |
|
|
| Aug 22, 2005 |
Press Release: Operating Costs in Clinical Trials Force CROs to Work with EDC, Life Science Insights Finds |
|
|
| Aug 22, 2005 |
Press Release: FDA Sends SuperGen Warning Letter Over Nipent Handout |
|
|
| Aug 22, 2005 |
Crain's Business: SEC sues two former Bristol-Myers execs |
|
|
| Aug 19, 2005 |
Press Release: Serono and Genmab Announce Global Development and Commercialization Agreement for Humax-CD4 |
|
|
| Aug 19, 2005 |
Press Release: Myogen Reports Positive Results for Darusentan Phase 2b Trial in Resistant Hypertension and Teva Announces Tentative Approval of Granisetron Hydrochloride Injection |
|
|
| Aug 19, 2005 |
Business Wire: Adecco's 'Where-the-Jobs-Are' Report Shows Increased Hiring in the Tech Sector in Wisconsin |
|
|
| Aug 19, 2005 |
PR Newswire: Medco Completes $2.3 Billion Acquisition of Accredo, Creates Largest Specialty/Biotech Pharmacy Operation |
|
|
| Aug 19, 2005 |
New York Business: Medco's buy of drug provider Accredo closes |
|
|
| Aug 15, 2005 |
Business Wire: Gilead and Achillion Announce Initiation of Phase I Clinical Trial Evaluating GS 9132 for the Treatment of Hepatitis C |
|
|
| Aug 15, 2005 |
Business Wire: DPT Laboratories Hosts Tour for FDA's Office of Generic Drugs |
|
|
| Aug 15, 2005 |
Business Wire: Curis CEO to Preside Over NASDAQ Closing Bell on August 16, 2005 |
|
|
| Aug 15, 2005 |
Press Release: Pfizer Acquires Antibody Discovery and Optimization Company |
|
|
| Aug 15, 2005 |
i-Newswire: Procrit® (Epoetin Alfa) Maintenance Treatment For Patients With Anemia From Chronic Kidney Disease |
|
|
| Aug 11, 2005 |
PR Newswire: Pharmaceutical Companies, Doctors, Health Care Providers and Patient Advocates Launch New Program to Help Uninsured South Dakota Residents Get Prescription Medicines |
|
|
| Aug 11, 2005 |
Crain's New York Business: Pfizer promises improved consumer ads |
|
|
| Aug 11, 2005 |
Press Release: Branded Drugs Gain New Hope in Battle Against Generics |
|
|
| Aug 11, 2005 |
PR Newswire: Newly Published Study Evaluates Extended Dosing Regimens of PROCRIT (Epoetin alfa) as Maintenance Treatment for Patients with Anemia from Chronic Kidney Disease |
|
|
| Aug 11, 2005 |
Yahoo News: Leading Geneticist and Advocate of the Human Genome Project (HGP) to Keynote Northwest VC Conference |
|
|
| Aug 9, 2005 |
UPI: Many reluctant to back HIV vaccine trials. |
|
|
| Aug 9, 2005 |
Press Release: Curis Reports Second Quarter 2005 Results |
|
|
| Aug 9, 2005 |
Business Wire: Genomatix Corporation Today Announced That It Has Changed Its Corporate Name to Intrexon Corporation |
|
|
| Aug 5, 2005 |
PR Newswire: Par Pharmaceutical Receives Final Approval to Market Clonazepam Orally Disintegrating Tablets |
|
|
| Aug 5, 2005 |
PR Newswire: Schering-Plough and Sankyo Enter License Agreement for Olmesartan in Select Latin American Territories |
|
|
| Aug 5, 2005 |
Business Week: Jobless claims fall, good sign for market |
|
|
| Aug 5, 2005 |
PR Newswire: Onyx Pharmaceuticals Reports Second Quarter and Six Month 2005 Financial Results |
|
|
| Aug 2, 2005 |
BrandWeek: The Wrong Prescription? New PhRMA Guidelines Fall Short |
|
|
| Aug 2, 2005 |
PR Newswire: Johnson & Johnson Adopts PhRMA Guidelines on Direct-to-Consumer Advertising |
|
|
| Aug 2, 2005 |
PR Newswire: Pfizer Statement On PhRMA Principles |
|
|
| Aug 2, 2005 |
PR Newswire: Generic Drug Makers Taking More Aggressive Approach Against Branded Drug Patents |
|
|
| Aug 2, 2005 |
Business Wire: Sepracor Adopts ''Guiding Principles'' for Consumer Advertising |
|
|
| Aug 2, 2005 |
Media Week: PhRMA Unveils New Guidelines |
|
|
| Aug 2, 2005 |
Press Release: N.C. Biosciences Organization makes push for Mass. Companies |
|
|
| Aug 2, 2005 |
PR Newswire: Issues and Solutions in Healthcare Through Intelligence and Strategy - Pharma & Biotech Competitive Intelligence Summit |
|
|
| Aug 2, 2005 |
Press Release: Solvay and Berna Biotech Sign a License Agreement for Vaccine Against Pseudomonas Aeruginosa in Cystic Fibrosis Patients |
|
|
| Aug 2, 2005 |
PR Newswire: ARCH Venture Partners Names Steve Gillis, Co-Founder of Immunex and Corixa, as Venture Partner |
|
|
| Aug 2, 2005 |
PR Newswire: FDA Leader Joins Quintiles' Regulatory Group |
|
|
| Aug 2, 2005 |
PR Newswire: Human Genome Sciences, Inc. Receives Milestone Payments From GlaxoSmithKline For GSK716155 Progress |
|
|
| Aug 2, 2005 |
PR Newswire: FDA Approves New Use For Celebrex; Pfizer Inc.'s Arthritis Drug To Add Warning |
|
|
| Aug 1, 2005 |
PR Newswire: Abgenix and Amgen Announce FDA Grants Panitumumab Fast Track Designation for Metastatic Colorectal Cancer |
|
|
| Aug 1, 2005 |
Business Wire: CureLab Awarded up to $ 7 Million NIH Grant |
|
|
| Aug 1, 2005 |
PR Newswire: Advancis Pharmaceutical Corporation Cuts Jobs In bid To Reduce Costs |
|
|
| Jul 31, 2005 |
i-Newswire: FDA approves Rozerem (ramelteon) for insomnia |
|
|
| Jul 31, 2005 |
i-Newswire: Barr Receives Approval For Allegra(R) Capsules |
|
|
| Jul 29, 2005 |
PR Newswire: Newt Gingrich and Novo Nordisk Join Georgia Business and Health Care Leaders in a Call-to-Action to Combat the Diabetes Epidemic |
|
|
| Jul 29, 2005 |
Press Release: Merck Announces Changes to Management Committee |
|
|
| Jul 29, 2005 |
Press Release: FDA’s Center for Drug Evaluation and Research Gets Permanent Leadership |
|
|
| Jul 28, 2005 |
PR Newswire: Millennium Reports Second Quarter 2005 Financial Results |
|
|
| Jul 26, 2005 |
PR Newswire: 281 Biotech CEOs Seek SBA Fix to Continue Their Medical Research |
|
|
| Jul 26, 2005 |
Press Release: Oncolytics Biotech Commences Patient Enrolment in U.K. Clinical Trial |
|
|
| Jul 25, 2005 |
Press Release: New Report Examines Biotech Giant Amgen's Success and Future Direction |
|
|
| Jul 25, 2005 |
i-Newswire: Scientists to Mimic Nature for Newest Cancer Drugs |
|
|
| Jul 22, 2005 |
PR Newswire: StayinFront and Dey L.P. Expand Partnership with New Hospital Sales Force Solution |
|
|
| Jul 22, 2005 |
PR Newswire: Roche Honors 100 Employees Nationwide for Exemplary Community Service as Part of its U.S. Centennial Celebration |
|
|
| Jul 22, 2005 |
i-Newswire: Scientists discover that three molecules may be developed into new Alzheimer's drugs |
|
|
| Jul 22, 2005 |
Business Wire: Gilead Sciences and Royalty Pharma Complete $525 Million Purchase from Emory University of Emtricitabine Royalty Interest |
|
|
| Jul 21, 2005 |
Press Release: Alfacell Corporation to Explore Uses for New Ribonuclease Drug Candidate |
|
|
| Jul 21, 2005 |
Press Release: Merck Announces Second-Quarter 2005 Earnings Per Share (EPS) of 33 Cents |
|
|
| Jul 21, 2005 |
PR Newswire: U.S. Adults Think it is a Good Idea to Forbid Direct-to-Consumer Advertising for Prescription Drugs When They First Come to Market |
|
|
| Jul 21, 2005 |
PR Newswire: Drug Companies Look to China to Conduct Clinical Trials |
|
|
| Jul 21, 2005 |
Press Release: Novartis Completes Acquisition of 98 Percent of Eon Labs |
|
|
| Jul 19, 2005 |
Business Wire: Amgen Releases Second Quarter 2005 Results |
|
|
| Jul 19, 2005 |
Press Release: Serono Delivers Strong Second Quarter Results |
|
|
| Jul 19, 2005 |
Press Release: Roche Acquires Swiss Based GlycArt Biotechnology |
|
|
| Jul 19, 2005 |
PR Newswire: Aptuit to Acquire Quintiles' Pharmaceutical Sciences, Preclinical Services and Clinical Trial Supplies |
|
|
| Jul 19, 2005 |
Press Release: Cornerstone BioPharma Further Expands Nationwide Sales Force |
|
|
| Jul 19, 2005 |
PR Newswire: Physicians Making 'E' a Way of Life |
|
|
| Jul 19, 2005 |
Business Wire: Teva Announces Tentative Approval of Tramadol and Acetaminophen Tablets |
|
|
| Jul 19, 2005 |
Press Release: New Clinical Studies & Evidence-based Medicine |
|
|
| Jul 18, 2005 |
PR Newswire: The Advisory Board Company Schedules First Quarter Investor Conference Call |
|
|
| Jul 18, 2005 |
Business Wire: aaiPharma Receives Court Approval of Pharmaceuticals Division Sale |
|
|
| Jul 18, 2005 |
PR Newswire: Michigan Attorney General Mike Cox Distributes $901,000 Cardizem Settlement to Michigan Consumers |
|
|
| Jul 18, 2005 |
Press Release: Adherex announces licensing deal with GlaxoSmithKline |
|
|
| Jul 15, 2005 |
Press Release: Doctors Sue Merck Over Vioxx Animal Tests |
|
|
| Jul 15, 2005 |
Press Release: NIH Ethics Problems More Widespread Than Previously Thought |
|
|
| Jul 14, 2005 |
Business Wire: Veteran Pharmaceutical and Biotech Industry Executives Unite in New, Independent Professional Association |
|
|
| Jul 14, 2005 |
PR Newswire: Triad Group to Release 21 Ideas for Boosting Biotechnology |
|
|
| Jul 13, 2005 |
Press Release: Genzyme And Project HOPE Partner To Rebuild Critical Health Care Programs In Tsunami-Affected Areas |
|
|
| Jul 13, 2005 |
Press Release: More Than 30 Leading Biotech and Medical Device Companies to Present at BIO Forum |
|
|
| Jul 13, 2005 |
Business Wire: Three Pharmaceutical Companies Become Charter Advertisers with African American Medical Network |
|
|
| Jul 13, 2005 |
PR Newswire: Transgenomic Projects Neutral to Positive Operating Cash Flow by Year-End |
|
|
| Jul 13, 2005 |
US Newswire: Penn to Provide Bioethics Training to Emerging Scientists |
|
|
| Jul 13, 2005 |
PR Newswire: Genentech Announces Intention to Offer up to $2 Billion in Senior Notes |
|
|
| Jul 13, 2005 |
PR Newswire: MicroRNA Field's Leading Scientists to Present at Nucleic Acid World Summit |
|
|
| Jul 12, 2005 |
Press Release: 10-year Tax Holiday for Pharma R&D Mooted |
|
|
| Jul 12, 2005 |
Marketwire: Healthcare Consulting Leads Industry Recovery |
|
|
| Jul 12, 2005 |
i-Newswire: Thoracic Cancer Patients Find New Hope with Alimta |
|
|
| Jul 11, 2005 |
PR Newswire: Two Patients Treated in First International Case Testing Drug-Eluting Stents To Treat Peripheral Arterial Disease |
|
|
| Jul 11, 2005 |
Business Wire: SurModics Announces Enrollment of First Patients in Clinical Trial for Treatment of Diabetic Macular Edema |
|
|
| Jul 11, 2005 |
Business Wire: Federal Jury Rules Against ACell and for Cook Biotech and Purdue Research Foundation in Patent Infringement Verdict |
|
|
| Jul 11, 2005 |
Business Wire: Proteus Launches PSI, a Full Protein-Related Service Business |
|
|
| Jul 11, 2005 |
Press Release: Omnicare to Acquire excelleRx to Expand Presence in Pharmacy and Disease Management |
|
|
| Jul 7, 2005 |
PR Newswire: Telik Reports Positive Clinical Data TELCYTA Regimens in Treatment of Lung Cancer |
|
|
| Jul 7, 2005 |
PR Newswire: Data for AstraZeneca's ZACTIMA Presented at World Conference on Lung Cancer |
|
|
| Jul 7, 2005 |
PR Newswire: GlaxoSmithKline (GSK) Exercises Option To LymphoStat-B(TM) |
|
|
| Jul 7, 2005 |
Business Wire: Millipore to Acquire NovAseptic AB: Broaden Offering to Biotech and Pharmaceutical Companies |
|
|
| Jul 7, 2005 |
Press Release: Ortho-McNeil to Develop Compounds for Asthma, Allergies |
|
|
| Jul 7, 2005 |
Press Release: Generic Pharmaceutical Maker to Acquire Amide |
|
|
| Jul 7, 2005 |
Yahoo News: ParAllele BioScience and Merck Collaborate to Discover Genetic Variations in Cancer |
|
|
| Jul 5, 2005 |
Business Wire: U.S. Pediatric Studies Have Led to New Labeling for Nearly 100 Drugs |
|
|
| Jul 1, 2005 |
PR Newswire: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Receives Not Approvable Letter From FDA for Tipifarnib Based on Phase II Data |
|
|
| Jul 1, 2005 |
Press Release: Bayer HealthCare Posts Information on Clinical Trials on the Internet |
|
|
| Jun 30, 2005 |
PR Newswire: Schering-Plough Announces FDA Approval of AVELOX (moxifloxacin HCl) for Treatment of Complicated Skin and Skin Structure Infections |
|
|
| Jun 30, 2005 |
PR Newswire: PAREXEL International Provides Financial Guidance |
|
|
| Jun 29, 2005 |
Business Wire: Merck Announces that FDA Has Accepted For Review Biologics License Applications for ROTATEQ and ZOSTAVAX |
|
|
| Jun 29, 2005 |
PR Newswire: Data Published In British Journal of Dermatology Show ENBREL Provided Psoriasis Patients Sustained Benefit After Dose Reduction |
|
|
| Jun 29, 2005 |
UPI: FDA to label ADHD drugs for side effects |
|
|
| Jun 29, 2005 |
Bloomberg: Glaxo Trails Merck in Cervical-Cancer Vaccine Race |
|
|
| Jun 29, 2005 |
PR Newswire: Executive Appointed to the BIO's Board of Directors |
|
|
| Jun 29, 2005 |
PR Newswire: Millennium Announces New CEO |
|
|
| Jun 29, 2005 |
London Free Press: Biovail retreats from U.S. |
|
|
| Jun 28, 2005 |
Marketwire: Pfizer slides on Viagra label news |
|
|
| Jun 28, 2005 |
PR Newswire: Basketball Star Alonzo Mourning Spreads the Word About Kidney Disease |
|
|
| Jun 28, 2005 |
Forbes: Lilly's Pipeline Not Fully Appreciated By Street |
|
|
| Jun 27, 2005 |
PR Newswire: GlaxoSmithKline (GSK) Announces Resupply Of Paxil CR To US Market |
|
|
| Jun 27, 2005 |
PR Newswire: GenoMed, Inc.'s West Nile Virus Treatment Abruptly Stopped, Patient Deteriorates |
|
|
| Jun 27, 2005 |
PR Newswire: New Research Shows Imitrex (Sumatriptan Succinate) Tablets Formulated With RT Technology Are Absorbed Faster Than Conventional Imitrex Tablets |
|
|
| Jun 26, 2005 |
PR Newswire: FDA Approves Roche's Oral Xeloda(R) For The Adjuvant Treatment Of Colon Cancer |
|
|
| Jun 26, 2005 |
Business Wire: Chiron Corporation Warns It Will Produce Fewer Flu Vaccines, Slashes Earnings Estimates; Stock Halted |
|
|
| Jun 24, 2005 |
Business Wire: Gilead Delivers Termination Notice to Roche for Tamiflu Development and Licensing Agreement |
|
|
| Jun 24, 2005 |
Salary.com: Report Identifies Paycheck-stretching Cities |
|
|
| Jun 24, 2005 |
LA Times (CA): Lure of Products Leads Drug Firms to Biotechs |
|
|
| Jun 24, 2005 |
PR Newswire: Pfizer To Purchase Up To $5 Billion Of Common Stock |
|
|
| Jun 24, 2005 |
PR Newswire: U.S. FDA Approves New Anti-HIV Drug Aptivus For Use In Combination Therapy |
|
|
| Jun 24, 2005 |
Business Wire: Phase II Clinical Results Announced for Merck/Lundbeck Sleep Drug |
|
|
| Jun 23, 2005 |
PR Newswire: Genelabs Technologies Receives Confirmation Of Orphan Drug Designation For Prestara |
|
|
| Jun 23, 2005 |
PR Newswire: VaxGen's Joint Venture, Celltrion, Inc., Signs Manufacturing Agreement With Bristol-Myers Squibb Company |
|
|
| Jun 23, 2005 |
PR Newswire: Protein Design Labs Sublicenses Rights To Develop Antibody-Drug Conjugates For Prostate Cancer To Genentech |
|
|
| Jun 22, 2005 |
PharmaLive: BIO 2005 Sets New Records, Introduces World to Tri-State Region's Strengths |
|
|
| Jun 22, 2005 |
Science Daily: Australia biotech looks for U.S. ties |
|
|
| Jun 21, 2005 |
PR Newswire: Celgene Corporation (CELG) Release: FDA Grants Priority Review For REVLIMID(R) NDA For Treatment Of Low- And Intermediate- Risk MDS With Deletion 5q Chromosomal Abnormality |
|
|
| Jun 21, 2005 |
Forbes: Genentech To Increase Diversity In Clinical Trials |
|
|
| Jun 21, 2005 |
PR Newswire: IntraBiotics Pharmaceuticals, Inc. (IBPI) Directors Resign, Company Terminates All Regular Workers |
|
|
| Jun 21, 2005 |
PR Newswire: Clinical Data To Acquire Genaissance Pharmaceuticals, Inc. (GNSC); $56 Million |
|
|
| Jun 21, 2005 |
PharmaLive.com: AstraZeneca and Humana Team Up to Improve Patient Compliance |
|
|
| Jun 20, 2005 |
The Scientist: Big Makeover for Big Pharma |
|
|
| Jun 20, 2005 |
The Scientist: Internet job sites are revolutionizing the job search process |
|
|
| Jun 16, 2005 |
Newsday (NY): Where the biotech money will go |
|
|
| Jun 2, 2005 |
New Scientist: New England, Join the Tea Party |
|
|
| May 30, 2005 |
Pharmaceutical Manufacturing: Three Tips to Get Your Resume Noticed Online |
|
|
| Mar 15, 2005 |
Bio-IT World: Microsoft Announces Digital Pharma Initiative |
|
|
| Mar 15, 2005 |
Boston Globe (MA): Stem-cell plan links biotechs, Genzyme, Viacell target a cure for juvenile diabetes |
|
|
| Oct 25, 2004 |
Business Journal of the Triad (NC): Sparking interest early a key to biotech staffing |
|
|
| Oct 5, 2004 |
MSNBC.com: Job-cut plans soar to 8-month high |
|
|
| Sep 14, 2004 |
JHU Gazette: Nursing to Expand Role of Clinical IT |
|
|
| Sep 9, 2004 |
Health-IT World: Toronto General Physicians Move to E-Prescribing via Misys CPR |
|
|
| Jul 29, 2004 |
Healthcare Informatics: Wireless Whereabouts: Demand is growing for unfettered information access |
|
|
| Jul 29, 2004 |
News 14 (NC): Edwards speaks about importance of innovation and technology |
|
|
| Jul 5, 2004 |
Boston Business Journal: Life sciences: Oxxon crosses the pond to get closer to talent |
|
|
| Jun 22, 2004 |
Fast Company: The Thrill of Defeat |
|
|
| Jun 7, 2004 |
Business Journal of Portland (OR): Independent pharmacists fill niche |
|
|
| Jun 7, 2004 |
South Florida Business Journal: Universities seeking space near Scripps |
|
|
| May 11, 2004 |
Bio-IT World: IBM Makes New Life-Sciences Tools Available |
|
|
| May 11, 2004 |
Bio-IT World: Pharma Revenue Compliance Tool Debuts |
|
|
| May 11, 2004 |
Bio-IT World: Sequences Set in Stone |
|
|
| May 3, 2004 |
Mass High Tech: PHC closes buy of clinical trial centers for $2M |
|
|
| May 3, 2004 |
Mass High Tech: Genzyme completes $215M buy of Impath’s oncology testing unit |
|
|
| Mar 25, 2004 |
Mass High Tech: NeoGenesis enters development deal with pharma giant AstraZeneca |
|
|
| Mar 25, 2004 |
Mass High Tech: Avant’s partner GlaxoSmithKline to invest in multimillion-dollar plant for rotavirus vaccine |
|
|
| Mar 25, 2004 |
Mass High Tech: Merrimack Pharmaceuticals wins SBIR grant for microarray biochips |
|
|
| Mar 25, 2004 |
Mass High Tech: Point Therapeutics to take in $13.5M in private placement |
|
|
| Mar 9, 2004 |
Bio-IT World: A Preventable Informatics Crime |
|
|
| Mar 9, 2004 |
Bio-IT World: Clinical Genomics - Proteomics Goes Cellular |
|
|
| Mar 9, 2004 |
Associated Press: Medicare Nominee Avoids Senators' Queries |
|
|
| Mar 8, 2004 |
Mass High Tech: Biotech the darling of financing mini-boom |
|
|
| Mar 1, 2004 |
News Observer (NC): Survivors of NC pharmaceutical plant explosion work in Nebraska |
|
|
| Mar 1, 2004 |
CNN Money: Texas Leaves Lilly's Zyprexa Off List |
|
|
| Feb 19, 2004 |
Star-Telegram (TX): Biotech industry could pick up slack as manufacturing slips in Michigan |
|
|
| Feb 19, 2004 |
Tri-Valley Herald Online (CA): White House recommends tracking device on drugs |
|
|
| Feb 19, 2004 |
BayNews9.com (FL): FDA wants other states to follow Florida's crackdown |
|
|
| Feb 19, 2004 |
Home News Tribune (NJ): U.S. jury examining books at Squibb |
|
|
| Feb 9, 2004 |
Tampa Bay Business Journal: Funding for informatics technology to benefit USF campus |
|
|
| Feb 5, 2004 |
Mass High Tech: GTC Biotherapeutics to reduce workforce by 20 percent |
|
|
| Feb 5, 2004 |
Mass High Tech: Anika gets FDA OK for Orthovisc, triggering $20M milestone |
|
|
| Jan 29, 2004 |
Mass High Tech: Genzyme gets OK to market Fabry disease drug in Japan |
|
|
| Jan 29, 2004 |
Mass High Tech: Boston Scientific gets reimbursement OK in France for Taxus stent |
|
|
| Jan 26, 2004 |
Masstechnology.com: GTC Biotherapeutics submits a European Market Authorization Application for ATryn® |
|
|
| Jan 14, 2004 |
Associated Press: Drug Shows Little Promise Vs. Lung Cancer |
|
|
| Jan 14, 2004 |
Bio-IT World: Users Tackle Linux Management |
|
|
| Jan 14, 2004 |
Mass High Tech: Synta Pharmaceuticals secures $50M in third round funding |
|
|
| Jan 7, 2004 |
Mass High Tech: Rhode Island secures $3 million grant for biotech manufacturing jobs |
|
|
| Jan 6, 2004 |
Bio-IT World: BIO Says 2003 Was Quite Good |
|
|
| Jan 5, 2004 |
Mass High Tech: Massachusetts' ZymeQuest collaborates with Chiron to develop universal donor blood |
|
|
| Jan 5, 2004 |
Mass High Tech: Dynogen to work with Johnson & Johnson research group on overactive bladder treatment |
|
|
| Jan 5, 2004 |
Mass High Tech: Repligen gets disappointing results from secretin in Autism study, stock plummets |
|
|
| Dec 29, 2003 |
Mass High Tech: Dyax gets good news in heart surgery trials of new drug |
|
|
| Dec 29, 2003 |
Detroit Free Press: Health care jobs are safe; Worker shortage to bring long-term security |
|
|
| Dec 23, 2003 |
Mass High Tech: Coley Pharmaceutical licenses VaxImmune to Chiron |
|
|
| Dec 23, 2003 |
Mass High Tech: GTC Biotherapeutics looks to raise $40 million in stock sales |
|
|
| Dec 19, 2003 |
InfoWorld: Biotech may be poised for "big year", Investment bank offers market predictions |
|
|
| Dec 17, 2003 |
Masstechnology.com: GTC Biotherapeutics Completes Enrollment in European Efficacy Study,
Recombinant Human Antithrombin III to be Named ATryn® |
|
|
| Dec 15, 2003 |
Mass High Tech: GTC swaps payments for equity stake in Merrimack Pharmaceuticals |
|
|
| Dec 10, 2003 |
Mass High Tech: Praecis Pharmaceuticals to work with National Cancer Institute on anti-tumor compound |
|
|
| Dec 9, 2003 |
Bio-IT World: Making Information-Based Medicine Work |
|
|
| Dec 9, 2003 |
Financial Times: The painful cure for Big Pharma |
|
|
| Dec 9, 2003 |
Boston.com: Boston looks to get drugs via Canada |
|
|
| Dec 9, 2003 |
Bio-IT World: GlaxoSmithKline Anticipates ‘Wall of New Products’ |
|
|
| Dec 3, 2003 |
Mass High Tech: Novogen given patent covering supplements pills based on soy isoflavones |
|
|
| Dec 3, 2003 |
Mass High Tech: Sepracor pulls the plug on rhinitis drug Soltara |
|
|
| Dec 2, 2003 |
Boston Globe: Biogen Idec goes into buy mode |
|
|
| Dec 2, 2003 |
Mass High Tech: Anika Therapeutics gets preliminary OK from FDA for osteoarthritis treatment |
|
|
| Dec 1, 2003 |
Mass High Tech: Altus Biologics gets Fast Track designation for pancreas drug |
|
|
| Nov 20, 2003 |
Health-IT World: E-Prescribing Is Optional in Latest Version of Medicare Bill |
|
|
| Nov 20, 2003 |
Health-IT World: Merck's Clinical Trial Strategy Just May Prove Prescient |
|
|
| Nov 18, 2003 |
Mass High Tech: Vitex halts enrollment of Phase III trial of Inactine |
|
|
| Nov 18, 2003 |
Mass High Tech: GenPath signs collaboration deal with pharma giant Merck |
|
|
| Nov 18, 2003 |
Mass High Tech: Genome Therapeutics to merge with Genesoft Pharmaceuticals |
|
|
| Nov 18, 2003 |
Time Magazine: The New Rules of Web Hiring |
|
|
| Nov 17, 2003 |
Mass High Tech: AdipoGenix reaches research milestone, lands $1M first round, NIH grants |
|
|
| Nov 14, 2003 |
Mass High Tech: Ariad Pharmaceuticals’ brain cancer therapy shows good results in trials |
|
|
| Nov 13, 2003 |
Mass High Tech: Pro-Pharmaceuticals award pair of patents for carbohydrate-based therapeutics |
|
|
| Nov 6, 2003 |
Mass High Tech: Acambis launches Phase I trials of West Nile vaccine |
|
|
| Nov 4, 2003 |
Bio-IT World: Working on the Pharma-IT Railroad |
|
|
| Nov 4, 2003 |
Bio-IT World: IT Services Prepped for Life Science Companies |
|
|
| Nov 4, 2003 |
Medical Economics: Online clinical data: An update |
|
|
| Nov 4, 2003 |
Health Data Exchange: XML Comes of Age for Data Exchange |
|
|
| Nov 4, 2003 |
American Medical News: Electronic prescribing and Medicare: Let the doctor decide |
|
|
| Nov 4, 2003 |
Health-IT World: HHS Declares War on Crummy Web Sites; Offers Guidelines |
|
|
| Nov 4, 2003 |
Mass High Tech: Life sciences industry comes under attack |
|
|
| Nov 3, 2003 |
Mass High Tech: Phase Forward makes a profit, signs deal with Eli Lilly |
|
|
| Oct 30, 2003 |
Health-IT World: Mass. Medical Society Teams with DrFirst on E-Prescribing |
|
|
| Oct 30, 2003 |
Mass High Tech: GenPath issued patent on cancer models |
|
|
| Oct 30, 2003 |
Mass High Tech: Genaissance Pharmaceuticals raises $11.1M |
|
|
| Oct 30, 2003 |
Mass High Tech: Biopure stock tanks on news of layoffs in face of FDA questions |
|
|
| Oct 29, 2003 |
Health-IT World: E-Prescribing's Impact Negligible on Formulary Compliance |
|
|
| Oct 29, 2003 |
New York Times: Illinois Seeks Permission to Buy Drugs |
|
|
| Oct 29, 2003 |
Bio-IT World: Buyer’s Market Beckons Biotech Investors |
|
|
| Oct 28, 2003 |
Mass High Tech: Collegium Pharmaceutical takes its first funding round |
|
|
| Oct 23, 2003 |
The Olympian (WA): Prescription medication stamped with new codes |
|
|
| Oct 23, 2003 |
Mass High Tech: AstraZeneca officially opens expanded R&D facility in Waltham |
|
|
| Oct 22, 2003 |
Mass High Tech: Cubist Pharmaceuticals closes public offering having raised $90M |
|
|
| Oct 21, 2003 |
Health-IT World: Congress Must Insert ‘Must,’ Not ‘May,’ to Put Teeth in E-Prescribing Law |
|
|
| Oct 21, 2003 |
Bio-IT World: Amersham and GE United by Shared Vision of Personalized Medicine |
|
|
| Oct 21, 2003 |
Mass High Tech: Vertex Pharmaceuticals gets FDA OK for new HIV drug |
|
|
| Oct 20, 2003 |
Associated Press: Eli Lilly Fights Drug Sales From Canada |
|
|
| Oct 13, 2003 |
Mass High Tech: European patent at core of infringement suit against TKT ruled invalid |
|
|
| Oct 8, 2003 |
Mass High Tech: Curis has Hedgehog protein IP well covered with latest patent |
|
|
| Oct 8, 2003 |
Mass High Tech: Critical Therapeutics fills $56M funding prescription in second round |
|
|
| Oct 7, 2003 |
Military Medical Technology: Pharmacy automation |
|
|
| Oct 7, 2003 |
Health-IT World: FDA Will Rely on Technology in Taking On Drug Counterfeiters |
|
|
| Oct 7, 2003 |
Mass High Tech: Collegium Pharmaceutical buys Tri-Nasal line from Muro |
|
|
| Oct 7, 2003 |
Mass High Tech: Altus Biologics gets grant to develop abdominal pain therapy |
|
|
| Oct 4, 2003 |
Yahoo/AP: Lawmakers to Defray E-Prescription Costs |
|
|
| Oct 3, 2003 |
Mass High Tech: Cubist, Chiron sign licensing agreement worth up to $50M |
|
|
| Oct 1, 2003 |
Mass High Tech: GenPath Pharmaceuticals grabs $42.7M in second round |
|
|
| Sep 30, 2003 |
Bio-IT World: Genome Transforms, Challenges Drug Discovery |
|
|
| Sep 30, 2003 |
Bio-IT World: FDA's McClellan Calls for More Sharing of Drug R&D Costs |
|
|
| Sep 30, 2003 |
The Stockton (CA) Record: Bar-code system prevents Rx mistakes |
|
|
| Sep 30, 2003 |
Healthleaders.com: Healthcare institutions are starting to take a more structured approach to healthcare implementations. |
|
|
| Sep 29, 2003 |
Mass High Tech: Avant’s anthrax vaccine research gets $3M funding for 2004 |
|
|
| Sep 25, 2003 |
EyeforPharma: Number of American “health seekers” online continues to grow |
|
|
| Sep 25, 2003 |
Mass High Tech: Genzyme gets OK for extended use of thyroid cancer test in Europe |
|
|
| Sep 25, 2003 |
Health-IT World: Quilogy, MMS Team Up on E-Prescriptions |
|
|
| Sep 23, 2003 |
Bio-IT World: CombinatoRx brings matchmaking to drug discovery and development |
|
|
| Sep 22, 2003 |
Mass High Tech: Number-cruncher Netezza enters bioinformatics area |
|
|
| Sep 22, 2003 |
Bio-IT World: GlaxoSmithKline Reveals Ingenuity |
|
|
| Sep 11, 2003 |
Bio-IT World: FDA Pushes Pharma Industry to Modernize |
|
|
| Sep 11, 2003 |
Bio-IT World: Safeguarding the Security of Clinical Data |
|
|
| Sep 10, 2003 |
Mass High Tech: Agencourt Bioscience to offer $10K grant for cancer research |
|
|
| Sep 3, 2003 |
Mass High Tech: Aphios to try to find SARS treatment under agreement with federal agencies |
|
|
| Sep 3, 2003 |
Mass High Tech: Acambis to work with Canadian biotech on better West Nile vaccine |
|
|
| Sep 2, 2003 |
Health-IT World: R.I. Physicians Taking Advantage of E-Prescriptions |
|
|
| Sep 1, 2003 |
The Business Review (Albany, NY): Albany College of Pharmacy sets sights on cytotechnology studies |
|
|
| Aug 25, 2003 |
Mass High Tech: Coley Pharmaceuticals raises $30M in private placement |
|
|
| Aug 21, 2003 |
Mass High Tech: Genzyme gets go-ahead for Renagel plant in U.K. |
|
|
| Aug 21, 2003 |
Health-IT World: Signature Genetics Boosts More Accurate Prescriptions |
|
|
| Aug 19, 2003 |
Bio-IT World: Biotech Execs Want Better Software for Their Scientists |
|
|
| Aug 19, 2003 |
Bio-IT World: Remaking the FDA in McClellan's Image |
|
|
| Aug 19, 2003 |
Bio-IT World: Conversation: Mervyn Jacobson; Playing by Aussie Rules |
|
|
| Aug 19, 2003 |
Mass High Tech: Alkermes to raise $100M in sale of notes |
|
|
| Aug 19, 2003 |
Mass High Tech: 454 Life Sciences buys exclusive rights to genome sequencing technology |
|
|
| Aug 18, 2003 |
Mass High Tech: Novogen wins patent on isoflavone technology |
|
|
| Aug 18, 2003 |
Mass High Tech: Alkermes creates alternative for alcohol treatment |
|
|
| Aug 18, 2003 |
Mass High Tech: Drug R&D costs cited for high prescription prices |
|
|
| Aug 18, 2003 |
USA Today: Fake drugs force makers to play spy games |
|
|
| Aug 13, 2003 |
Bio-IT World: Doing Well with High-Throughput Custom Microplate-Based System |
|
|
| Aug 13, 2003 |
Mass High Tech: Physiome Sciences, Predix announce merger |
|
|
| Aug 13, 2003 |
Bio-IT World: Orphan Drugs: For Love or Money? |
|
|
| Aug 11, 2003 |
Mass High Tech: TKT takes European rights for gene therapy back from Wyeth. |
|
|
| Aug 11, 2003 |
Mass High Tech: Genome Therapeutics gets milestone cash from Amgen |
|
|
| Aug 7, 2003 |
Mass High Tech: Biogen-IDEC merger gets FDA OK |
|
|
| Aug 5, 2003 |
Mass High Tech: Pennwest Pharmaceuticals raises $52.7M in stock sales |
|
|
| Aug 4, 2003 |
Business Journal of the Triad (NC): The right fit: Assessment tools help firms hire the right employees |
|
|
| Aug 4, 2003 |
Mass High Tech: NeoGenesis signs drug discovery deal with Amgen |
|
|
| Aug 4, 2003 |
Mass High Tech: Genzyme to buy Calif |
|
|
| Aug 1, 2003 |
Mass High Tech: ImmunoGen signs collaboration deal with Aventis, gets
$12M up front |
|
|
| Aug 1, 2003 |
Mass High Tech: FDA wants more info from Biopure |
|
|
| Jul 31, 2003 |
Mass High Tech: GTC Biotherapeutics raises $12M in private placement |
|
|
| Jul 29, 2003 |
Mass High Tech: Cubist lands a pair of SBIR grants |
|
|
| Jul 28, 2003 |
Mass High Tech: Oxigene stock soars on news of orphan drug status for thyroid cancer drug |
|
|
| Jul 28, 2003 |
Mass High Tech: Avaki unveils its stealth mega-customer: Pfizer |
|
|
| Jul 24, 2003 |
Mass High Tech: Biopure raises $17M in stock sale |
|
|
| Jul 23, 2003 |
Yahoo/Dow Jones: ISoft In Advanced Merger Talks To Buy Torex |
|
|
| Jul 23, 2003 |
Mass High Tech: Pintex Pharmaceuticals gets patent on cancer-linked enzyme |
|
|
| Jul 23, 2003 |
Mass High Tech: Genome Therapeutics gets patent on drug-resistant bug |
|
|
| Jul 23, 2003 |
Mass High Tech: TKT gets OK from Europe to make Replagal in Cambridge |
|
|
| Jul 21, 2003 |
Bio-IT World: Novartis Half-Year Finishes Strong |
|
|
| Jul 21, 2003 |
The Business Journal (Minneapolis): Changing careers? Tap cross-over skills, talk to people in field |
|
|
| Jul 18, 2003 |
Bio-IT World: Genzyme Q2 Revenue Up, but Income Dips |
|
|
| Jul 18, 2003 |
Bio-IT World: Antibody Deal Affects Idec Q2, but Income Rises |
|
|
| Jul 18, 2003 |
Bio-IT World: Report: The Failure of Clinical IT |
|
|
| Jul 17, 2003 |
Bio-IT World: Congress Questions US Supercomputing Efforts |
|
|
| Jul 17, 2003 |
Health-IT World: UPitt IRB Goes with Webridge, Fraser Health with GE Medical |
|
|
| Jul 17, 2003 |
Mass High Tech: TransForm Pharma wins DARPA contract |
|
|
| Jul 17, 2003 |
Mass High Tech: ArQule to buy Cyclis Pharmaceuticals for $25M |
|
|
| Jul 15, 2003 |
Bio-IT World: Clinical Trials: Patient, Record Thyself |
|
|
| Jul 15, 2003 |
Bio-IT World: Buying Power |
|
|
| Jul 15, 2003 |
Bio-IT World: Stem Cell Suicide |
|
|
| Jul 10, 2003 |
Training Magazine: Pharmaceutical Sales: First-Year Reps Complete 302 Hours Initial Training |
|
|
| Jul 10, 2003 |
Health-IT World: Genomic Advances of Past Decade Are Real: Ordoñez |
|
|
| Jul 10, 2003 |
Health-IT World: Galson Maps Out FDA IT Agenda Under McClellan |
|
|
| Jul 8, 2003 |
Bio-IT World: Signs of Intelligent Data Handling |
|
|
| Jul 8, 2003 |
Health-IT World: AMA Issues Guidelines for Online Prescriptions |
|
|
| Jul 8, 2003 |
Health-IT World: Diabetics, Elderly Top Buyers of Online Prescriptions |
|
|
| Jul 8, 2003 |
Daily Herald (Chicago): Allscripts puts faith in physicians |
|
|
| Jul 7, 2003 |
South Florida Sun Sentinel: Hospitals seek solutions to reduce drug mistakes |
|
|
| Jul 7, 2003 |
Tucson (Arizona) Citizen: System could prevent Rx mistakes |
|
|
| Jul 3, 2003 |
Health-IT World: Patient, Record Thyself ... and No Fibbing |
|
|
| Jul 2, 2003 |
Florida Today: Sign of the times: doctors must write neater prescriptions |
|
|
| Jul 2, 2003 |
Mass High Tech: Cubist move reduces future royalties to Lilly |
|
|
| Jul 1, 2003 |
Bio-IT World: Bill seeks free access to federally funded research |
|
|
| Jul 1, 2003 |
Monterey (CA) Herald: Computer fills prescriptions faster |
|
|
| Jul 1, 2003 |
Health-IT World: Electronic Prescriptions Mandated by Medicare Bills |
|
|
| Jun 30, 2003 |
Mass High Tech: Quiety confident: Bio executives say ‘anything is possible’ in biotech business |
|
|
| Jun 25, 2003 |
Mass High Tech: Boston Scientific to appeal German court decision on stent patent |
|
|
| Jun 24, 2003 |
Mass High Tech: Coley gets another $6M from DARPA for anthrax vaccine booster |
|
|
| Jun 23, 2003 |
Mass High Tech: Biogen to merge with IDEC Pharmaceuticals |
|
|
| Jun 23, 2003 |
Mass High Tech: Proteologics proposes drug ‘revolution’ for HIV, other viruses |
|
|
| Jun 20, 2003 |
Mass High Tech: Vion Pharmaceuticals lines up $5M in private placement |
|
|
| Jun 19, 2003 |
Mass High Tech: Indevus launches Phase II trials of HIV-stopping ointment |
|
|
| Jun 19, 2003 |
Bio-IT World: Harvard and MIT’s Broad vision |
|
|
| Jun 18, 2003 |
Mass High Tech: CardioTech unit gets FDA OK for coated bypass products |
|
|
| Jun 18, 2003 |
CNN: FDA approves first nasal mist flu vaccine |
|
|
| Jun 17, 2003 |
Bio-IT World: Novartis group selects SAP Pharmaceuticals |
|
|
| Jun 17, 2003 |
Bio-IT World: First drug approved with electronic patient diary data |
|
|
| Jun 17, 2003 |
Mass High Tech: Pharma fights big jury awards, junk science |
|
|
| Jun 17, 2003 |
Health-IT World: Mossberg Pushes for Health-Focused PDAs |
|
|
| Jun 15, 2003 |
Bio-IT World: Genomics Companies must Fill the Pipeline or Face the Music |
|
|
| Jun 15, 2003 |
Bio-IT World: Mouse Hunt |
|
|
| Jun 13, 2003 |
Mass High Tech: Biogen buys rights to protein patents |
|
|
| Jun 13, 2003 |
Bio-IT World: Intradigm and Sequitur ink key RNAi deal |
|
|
| Jun 12, 2003 |
Mass High Tech: Ariad signs extended licensing deal with GPC Biotech |
|
|
| Jun 12, 2003 |
Mass High Tech: Curis signs $8.5M licensing deal with Genentech |
|
|
| Jun 6, 2003 |
Bio-IT World: Senator Clinton supports bioinformatics initiative |
|
|
| Jun 5, 2003 |
Mass High Tech: Genome Therapeutics puts $15M in debt into early retirement |
|
|
| Jun 5, 2003 |
Mass High Tech: Millennium to close facilities, cut 600 jobs |
|
|
| Jun 4, 2003 |
Mass High Tech: Coley Pharmaceuticals wins $6M anthrax vaccine contract extension |
|
|
| Jun 4, 2003 |
Mass High Tech: Oxigene stock soars on fast track designation of thyroid cancer drug |
|
|
| Jun 2, 2003 |
Bio-IT World: Genomic Health reveals its business plan |
|
|
| Jun 2, 2003 |
Bio-IT World: Genetics consortium forges ahead with oncology database |
|
|
| Jun 2, 2003 |
Bio-IT World: Roche unveils two pharmacogenomic developments |
|
|
| May 29, 2003 |
National Post (Canada): Online prescriptions could save lives: report |
|
|
| May 29, 2003 |
Business Week: Five Hurdles for Biotech |
|
|
| May 29, 2003 |
Health IT World: Should FDA Mandate Bar Codes for Each Capsule? |
|
|
| May 29, 2003 |
Mass High Tech: Biogen gets OK for prefilled Avonex syringes |
|
|
| May 29, 2003 |
Mass High Tech: CombinatoRx gets its first drug patent |
|
|
| May 29, 2003 |
Bio-IT World: New NIH bioinformatics director ready for task ahead |
|
|
| May 28, 2003 |
Mass High Tech: Biotech startup Compound Therapeutics lands $12M in first round |
|
|
| May 28, 2003 |
Pittsburgh Business Times: NDCHealth buys TechRx |
|
|
| May 27, 2003 |
Mass High Tech: OxiGene stock soars on news of cancer-starving treatment |
|
|
| May 26, 2003 |
BizJournals.com: Cold calls teach you how to 'fail' to succeed |
|
|
| May 23, 2003 |
Mass High Tech: Drug development price tag nears $900 million, according to Tufts study |
|
|
| May 22, 2003 |
Health-IT World: SAS's Goodnight Survives an Ambush |
|
|
| May 22, 2003 |
Mass High Tech: Millennium announces improvements with colitis drug |
|
|
| May 21, 2003 |
Bio-IT World: MIT starts construction of McGovern Institute |
|
|
| May 21, 2003 |
Mass High Tech: Momenta Pharmaceuticals secures $19 million |
|
|
| May 9, 2003 |
Mass High Tech: Ariad licenses technology to DiscoveRx |
|
|
| May 6, 2003 |
CNN: U.S. clears lung-cancer drug |
|
|
| May 5, 2003 |
Mass High Tech: Alternative to antibiotics not a passing phage |
|
|
| May 1, 2003 |
Mass High Tech: Genzyme and partner gets FDA OK for Aldurazyme |
|
|
| Apr 28, 2003 |
Tampa Bay Business Journal: HIPAA helping tech sector hop to next wave in health care |
|
|
| Apr 25, 2003 |
Mass High Tech: Elixir Pharma joins genome institute to study longevity |
|
|
| Apr 25, 2003 |
Mass High Tech: Implant Sciences wins $100K grant |
|
|
| Apr 25, 2003 |
Mass High Tech: FDA OKs Genzyme’s Fabry disease treatment |
|
|
| Apr 9, 2003 |
Mass High Tech: Curis granted patent for cancer drug candidate compounds |
|
|
| Apr 7, 2003 |
Mass High Tech: Curis reports treatment candidate for skin cancer |
|
|
| Apr 2, 2003 |
Mass High Tech: Sepracor gets notice of FDA filing for insomnia drug |
|
|
| Mar 31, 2003 |
Washington Business Journal: Expert Opinion: Biotech growth in 2003: The catalysts for success |
|
|
| Mar 31, 2003 |
Mass High Tech: Novartis to pay up to $850 million to play role in Idenix Pharmaceuticals’ drug developments |
|
|
| Mar 26, 2003 |
Mass High Tech: Biopure private stock sale raises $13.4M |
|
|
| Mar 26, 2003 |
Mass High Tech: Idenix Pharmaceuticals to sell majority interest to Novartis |
|
|
| Mar 24, 2003 |
Business First of the Greater Triad (NC): N.C. biotechs optimistic about adding new jobs |
|
|
| Mar 17, 2003 |
Business Journal of the Triad (NC): Pharma firms plan to add 1,000 jobs |
|
|
| Mar 3, 2003 |
Philadelphia Business Journal: Expert backs N.J. research plan |
|
|
| Feb 3, 2003 |
Business Journal of Greater Triad (NC): Triad, others vie for $35M biotech training center |
|
|
| Feb 3, 2003 |
Triangle Business Journal (NC): RTP courts $200M project |
|
|
| Jan 20, 2003 |
CNN: Supreme Court to hear arguments on Maine drug discount law |
|
|
| Jan 13, 2003 |
Boston Business Journal: New drug stirs hiring at Abbott |
|
|
| Jan 8, 2003 |
San Francisco Business Times: Chiron, Glaxo target obesity |
|
|
| Jan 6, 2003 |
San Francisco Business Times: Pfizer settles with California on antibiotic ads |
|
|
| Jan 6, 2003 |
Philadelphia Business Journal: Biotech/pharmaceuticals: Drugmakers battle funding, patent woes: FDA action expected on several potential products |
|
|
| Jan 6, 2003 |
Puget Sound Business Journal (Seattle): http://seattle.bizjournals.com/seattle/stories/2003/01/06/focus13.html |
|
|
| Jan 6, 2003 |
San Jose Business Journal: Forecast for 2003 points to information technology, health industry recoveries |
|
|
| Dec 30, 2002 |
Boston Business Journal: State crafting deal to lure pharma plant |
|
|
| Dec 30, 2002 |
The Business Review: N.Y. urged to embrace pharmaceutical industry |
|
|
| Dec 30, 2002 |
Boston Business Journal: Look out Bay State: North Carolina wants our biotechs |
|
|
| Dec 30, 2002 |
Boston Business Journal: Biomarketing firm lands Novartis |
|
|
| Dec 23, 2002 |
Boston Business Journal: Cash-strapped biotechs seeking partnership deals |
|
|
| Dec 20, 2002 |
Genome Web: Perlegen Announces Two More Pharma Collaborations |
|
|
| Dec 20, 2002 |
Genome Web: Valentis Licenses GeneSwitch to Schering, Pockets $1.1M |
|
|
| Dec 19, 2002 |
Newsday: U.S. Storefronts Offer Cheap Canada Drugs |
|
|
| Dec 18, 2002 |
Washington Post: Panel Backs MedImmune's Nasal-Spray Flu Vaccine |
|
|
| Dec 18, 2002 |
Boston Globe: Performing corporate CPR |
|
|
| Dec 17, 2002 |
Associated Press: Biotech Firm to Slash AIDS Drug Price |
|
|
| Dec 17, 2002 |
Bio IT World: Millennium to lay off 100 |
|
|
| Dec 17, 2002 |
Forbes.com: Genomics Revolution Actually Happens |
|
|
| Dec 16, 2002 |
Boston Business Journal: Cato Research will open a Waltham office |
|
|
| Dec 16, 2002 |
Boston Business Journal: Biomed Report: Grants grow plentiful, but feds retain hold on leash |
|
|
| Dec 16, 2002 |
Greater Triad Business Journal: Now is the time for Triad to push for biotech office |
|
|
| Dec 13, 2002 |
Bio IT World: Bioinformatics.org creates global grid |
|
|
| Dec 12, 2002 |
UPI: ImClone: High-flying biotech a year later |
|
|
| Dec 12, 2002 |
Genome Web: Scimagix, Roche in Protein Informatics Collaboration |
|
|
| Dec 12, 2002 |
Bio IT World: DNA for Dummies? |
|
|
| Dec 5, 2002 |
Bio IT World: Millennium speeds cancer drug tests amid shakeup |
|
|
| Dec 3, 2002 |
Bio IT World: InforMax Launches String Of Enhanced Analytical Tools |
|
|
| Dec 3, 2002 |
Bio IT World: The Business of Bioinformatics |
|
|
| Dec 3, 2002 |
Bio IT World: Divide and Distribute |
|
|
| Dec 2, 2002 |
EyeforPharma: RWD Technologies Develops Integrated Medical Information System for Aventis |
|
|
| Dec 2, 2002 |
EyeforPharma: InfoMedics Concludes First Patient Experience Feedback Program in Europe for Novartis |
|
|
| Dec 2, 2002 |
EyeforPharma: Molecular Mining announces gene network collaboration with GlaxoSmithKline |
|
|
| Nov 25, 2002 |
Philadelphia Business Journal: R&D lapse, cost-cutting hurting drug industry |
|
|
| Nov 25, 2002 |
San Francisco Business Times: Singed by tech flame-out, PR firms like look of biotech |
|
|
| Nov 25, 2002 |
Atlanta Business Chronicle: Biotech under microscope |
|
|
| Nov 25, 2002 |
Philadelphia Business Journal: Schools push training programs for research |
|
|
| Nov 25, 2002 |
Philadelphia Business Journal: Biotechs feel pain |
|
|
| Nov 19, 2002 |
Bio IT World: Biotechs desperately seeking storage management |
|
|
| Nov 19, 2002 |
Bio IT World: Update: Nextphase releases Tablet PC clinical trial software |
|
|
| Nov 19, 2002 |
Bio IT World: Amid Q3 red ink and layoffs, Incyte acquires Maxia |
|
|
| Nov 18, 2002 |
Memphis Business Journal: British officials seek to partner with Memphis on biotech issues |
|
|
| Nov 18, 2002 |
Mass High Tech: UMass gets on course with bio, science |
|
|
| Nov 12, 2002 |
Bio IT World: Analysis: Invitrogen and InforMax a complementary fit |
|
|
| Nov 12, 2002 |
Bio IT World: I3C digs deeper |
|
|
| Nov 12, 2002 |
Bio IT World: Things change (maybe even at Big Pharma) |
|
|
| Nov 12, 2002 |
Bio IT World: Strategic Insights: Genes & Liens |
|
|
| Nov 12, 2002 |
Bio IT World: Interview: John Craig Venter Unvarnished |
|
|
| Nov 12, 2002 |
EyeforPharma.com: Know (and engage) thy enemy |
|
|
| Nov 12, 2002 |
Bio IT World: Clinical Data Standards Face Uphill Battle |
|
|
| Nov 11, 2002 |
Phoenix Business Journal: Biotech boost could be just what the doctor ordered |
|
|
| Nov 8, 2002 |
EyeforPharma.com: SciQuest completes implementation of Enterprise Substance Manager at Aventis |
|
|
| Nov 8, 2002 |
EyeforPharma.com: AstraZeneca joins with LeapFrog to develop customized health education book |
|
|
| Nov 7, 2002 |
EyeforPharma.com: Scimagix and Amersham Biosciences to develop image informatics solution |
|
|
| Nov 7, 2002 |
EyeforPharma.com: Novartis expands use of Ciphergen’s Biomaker Discovery Centers and SELDI ProteinChip Technology |
|
|
| Nov 5, 2002 |
Genome Web: Facing Capital Crunch, Biopharmas Rejigger R&D Spending (Hint: It Ain’t In Tool Shops) |
|
|
| Nov 4, 2002 |
Boston Business Journal: Biotech work force curious as to Novartis' hiring plans |
|
|
| Nov 4, 2002 |
St. Louis Business Journal: BioBelt earns recognition but wants more capital |
|
|
| Nov 4, 2002 |
San Francisco Business Times: Fremont biopharma company grooves to its own B-bop |
|
|
| Nov 4, 2002 |
St. Louis Business Journal: McCarthy, Tarlton, Alberici building biotech business |
|
|
| Nov 4, 2002 |
Pugent Sound Business Journal: Agency pushes new drug-marketing guidelines |
|
|
| Oct 28, 2002 |
East Bay Business Times: Firm hunts down drugs to develop |
|
|
| Oct 28, 2002 |
Philadelphia Business Journal: Researcher helps pharma firms improve drugs |
|
|
| Oct 28, 2002 |
The Business Journal of the Greater Triad Area: Viewpoint: FDA patent law will harm Triad's biotech economy |
|
|
| Oct 28, 2002 |
Philadelphia Business Journal: Drug researcher puts new twists on old methods |
|
|
| Oct 25, 2002 |
CNN: Survey finds drug company research raises suspicion |
|
|
| Oct 21, 2002 |
The Business Journal of Phoenix: Biotech training gaining support |
|
|
| Oct 21, 2002 |
The Business Journal (Raleigh/Durham): 'Golden' funding headed to biotech |
|
|
| Oct 21, 2002 |
Austin Business Journal: $265M investment weighed: Four sites under consideration in Austin for pharmaceutical plant |
|
|
| Oct 14, 2002 |
San Francisco Business Times: In biotech, partnering is such sweet sorrow |
|
|
| Oct 14, 2002 |
Greensboro/Winston Business Journal: Universities seek ways to revive biotech training site |
|
|
| Oct 9, 2002 |
Bio IT World: The Appliance of Sequence |
|
|
| Oct 9, 2002 |
Bio IT World: Apple's Life Science Efforts on Verge of Bearing Fruit |
|
|
| Oct 9, 2002 |
Bio IT World: The Path to Personalized Medicine |
|
|
| Oct 9, 2002 |
Bio IT World: Cracking the 'Druggable Genome' |
|
|
| Oct 8, 2002 |
Bio IT World: Hitachi Soft develops low-cost human genome DNA chip |
|
|
| Sep 27, 2002 |
Boston Globe: Boston scientific lauds results on drug-coated device |
|
|
| Sep 25, 2002 |
Boston Globe: Some biotech firms bypass Cambridge for the suburbs |
|
|
| Sep 23, 2002 |
Yahoo News: Using Aspirin or NSAIDs Cuts Alzheimer's Risk |
|
|
| Sep 18, 2002 |
Boston Globe: Boston area proves a lure for biotech sector |
|
|
| Sep 16, 2002 |
Cincinnati Business Courier: RxBazaar goes public with reverse merger: Online drug distributor's stock not yet traded |
|
|
| Sep 16, 2002 |
Memphis: HIPAA privacy rules will impact drug marketing |
|
|
| Sep 16, 2002 |
Minneapolis Business Journal: Drug industry blooming here |
|
|
| Sep 16, 2002 |
Raleigh/Durham Business Journal: $35M NCSU unit would aid biotech |
|
|
| Sep 16, 2002 |
Business Journal of the Triad: Darr resigns from post at N.C. Biotech Center |
|
|
| Sep 13, 2002 |
Ananova: Bayer additional job cuts right step but pharma problems linger - analysts |
|
|
| Sep 13, 2002 |
BBC: Bringing the genetic lab to you |
|
|
| Sep 13, 2002 |
BBC: Pensioner markets device to split Viagra pill |
|
|
| Sep 13, 2002 |
The Star: GlaxoSmithKline and Diethelm signs multi-million ringgit distribution contract |
|
|
| Sep 12, 2002 |
TheStreet.com: Genentech's Pipeline Could Have Some Clogs |
|
|
| Sep 12, 2002 |
Boston Globe: Biotech firm suspends operations |
|
|
| Sep 11, 2002 |
Boston Globe: Genentech cancer drug fails key test |
|
|
| Sep 11, 2002 |
Boston Globe: Novartis sees potential for partnerships |
|
|
| Sep 9, 2002 |
Greensboro Business Journal: Battle for Pilot Therapeutics raises important policy questions |
|
|
| Sep 6, 2002 |
CNN: AstraZeneca buoyed by cancer drug use |
|
|
| Sep 2, 2002 |
CNN: Strong drug sales lift Sanofi |
|
|
| Aug 30, 2002 |
Boston Business Journal: Help wanted: Even in lean times, Partners is hungry for workers |
|
|
| Aug 29, 2002 |
CNN: The good and bad of going over-the-counter |
|
|
| Aug 28, 2002 |
Baltimore Business Journal: Contract manufacturing has proven to be right plan |
|
|
| Aug 27, 2002 |
CNN: Choosing an antidepressant gets tougher |
|
|
| Aug 25, 2002 |
CNN: Problem-solvers rewarded in novel search for researchers |
|
|
| Aug 23, 2002 |
Boston Business Journal: With $52M, Archemix heats up venture capital climate |
|
|
| Aug 16, 2002 |
CNN: Cheap AIDS drug set for China market |
|
|
| Aug 16, 2002 |
Bio IT World: Researchers’ island mentality hinders drug development |
|
|
| Aug 16, 2002 |
Bio IT World: PwC to bolster business side of IBM’s life science consulting |
|
|
| Aug 16, 2002 |
Albany Business Review: Flow acquires Schering-Plough Web site for docs |
|
|
| Aug 16, 2002 |
Raleigh/Durham Business Journal: RTP evolves from textiles to biotech |
|
|
| Aug 15, 2002 |
CNN: Researchers laud new antidepressant |
|
|
| Aug 14, 2002 |
CNN: Report: Big tobacco pressured drug makers |
|
|
| Aug 13, 2002 |
Bio IT World: Clusters and Candy Wrappers |
|
|
| Aug 13, 2002 |
Bio IT World: Necessary Liaisons: Making Standards Work |
|
|
| Aug 12, 2002 |
CNN: FDA approves new option for colon cancer |
|
|
| Aug 12, 2002 |
St. Louis Business Journal: Hill leads Express Scripts into growth |
|
|
| Aug 6, 2002 |
CNN: Dr. Sanjay Gupta: 'Barbie drug' boosts libido? |
|
|
| Aug 6, 2002 |
NewsMax: Anthrax Vaccine Maker Says Its Future Is in Doubt |
|
|
| Aug 6, 2002 |
CNN: Lawyers: Companies knew about diluted cancer drugs |
|
|
| Aug 6, 2002 |
US News & World Report: Discounts by pharmaceutical companies to middlemen are under fire |
|
|
| Aug 6, 2002 |
GenomeWeb: New University Degree Programs Fuel Surge in Bioinformatics Grads in ‘02 |
|
|
| Aug 5, 2002 |
Infoworld: IBM Bundles Storage Hardward for Biotech |
|
|
| Aug 3, 2002 |
New York Times: Out of the Merger Rush, Merck's on a Limb |
|
|
| Aug 3, 2002 |
Boston Globe: US probes drug firm incentive at Lahey |
|
|
| Aug 2, 2002 |
Business Journal of the Triangle: GSK tops bank in campaign funding |
|
|
| Aug 2, 2002 |
Washington Business Journal: New MedImmune Ventures to invest 'smart money' |
|
|
| Aug 2, 2002 |
San Francisco Business Times: Gene researchers find big shortcuts in tiny tubes |
|
|
| Aug 2, 2002 |
Minneapolis Business Journal: Venture capitalists balance portfolios between device makers and biotech firms |
|
|
| Aug 2, 2002 |
Wichita Business Journal: Cash-poor biotechnology firms enduring grim funding prospects |
|
|
| Aug 2, 2002 |
East Bay Business Times: Health care pumps in venture cap dollars |
|
|
| Jul 29, 2002 |
CNN: China's bogus medicines kill thousands a year |
|
|
| Jul 29, 2002 |
Philadelphia Business Journal: Region emerges as a player in drug software |
|
|
| Jul 29, 2002 |
Houston Business Journa: Houston working to step up to the plate in biotech world |
|
|
| Jul 29, 2002 |
Houston Business Journa: Houston proves itself as major player in biotech community |
|
|
| Jul 26, 2002 |
CNN: Compromise emerges on prescription drugs |
|
|
| Jul 26, 2002 |
CNN: Schering sees double-digit profit |
|
|
| Jul 26, 2002 |
Science Magazine: Shortage? What Shortage? |
|
|
| Jul 26, 2002 |
Seattle Times: European panel OKs Icos' impotence drug |
|
|
| Jul 25, 2002 |
CNN: Generic delays help AstraZeneca |
|
|
| Jul 25, 2002 |
Washington Post: In Search Of a Place On Genetic Science Map |
|
|
| Jul 25, 2002 |
Boston Globe: A growth plan tied to a gene |
|
|
| Jul 25, 2002 |
Washington Post: Human Genome Sciences Reports Wider Loss |
|
|
| Jul 25, 2002 |
San Francisco Chronicle: Biotech firms worry about red tape in antiterror laws |
|
|
| Jul 24, 2002 |
CNN: Institute of Medicine to evaluate supplements |
|
|
| Jul 24, 2002 |
CNN: Asthma drug boosts GSK |
|
|
| Jul 24, 2002 |
CNN: Impotence drug delayed |
|
|
| Jul 19, 2002 |
CNN: Prescription drug debate heats up the Hill |
|
|
| Jul 19, 2002 |
CNN: Solid sales expected from Novartis |
|
|
| Jul 19, 2002 |
San Francisco Business Times: Biotech firms act to avoid final curtain |
|
|
| Jul 18, 2002 |
CNN: FDA approves 'date rape drug' for rare disease |
|
|
| Jul 15, 2002 |
Mass High Tech: Millennium Pharma stops asthma treatment program |
|
|
| Jul 12, 2002 |
Infoworld: Healthy challenges |
|
|
| Jul 12, 2002 |
Science Magazine: Moving Between Disciplines: Snakes or Ladders? |
|
|
| Jul 11, 2002 |
Bio IT World: Science Still Reigns in Bio-IT |
|
|
| Jul 11, 2002 |
The News-Record: Hospitals scramble for drugs |
|
|
| Jul 8, 2002 |
USA Today: Job growth will be gradual as economy improves |
|
|
| Jul 3, 2002 |
CNN: Aventis net up on cancer drug |
|
|
| Jun 28, 2002 |
CNN: House approves Rx drug plan |
|
|
| Jun 28, 2002 |
Portland Business Journal: Wanted: pharmacists, dental assistants |
|
|
| Jun 26, 2002 |
Bio-IT World: Biotech & Infotech: Bioinformatics is dead! Long live bioinformatics? |
|
|
| Jun 12, 2002 |
Bio-IT World: FDA Fosters Pharmacogenomics |
|
|
| Jun 12, 2002 |
Bio-IT World: Variations on a Theme |
|
|
| Jun 12, 2002 |
Bio-IT World: Fly Fishing on the Brain |
|
|
| Jun 11, 2002 |
SFGate.com: States, cities try to lure biotechnology companies |
|
|
| May 14, 2002 |
EyeforPharma: The oncoming challenges for big pharma, and how you can avoid the pitfalls |
|
|
| Apr 19, 2002 |
InfoWorld: Bio-IT market to reach $38 billion in 2006 |
|
|
| Apr 12, 2002 |
CNN: Schering sees double-digit growth |
|
|
| Apr 11, 2002 |
CNN: Researchers: Pill may someday replace exercise |
|
|
| Apr 9, 2002 |
CNN: Drug stabilizes cancer growth minus side effects |
|
|
| Apr 4, 2002 |
CNN: Pharmacist shortage means lucrative offers for grads |
|
|
| Apr 1, 2002 |
CNN: Cancer: a new frontier for arthritis drugs |
|
|
| Mar 29, 2002 |
CNN: Prescription drugs costs surge -- again |
|
|
| Mar 26, 2002 |
CNN: Researcher sees possible Prozac cancer link |
|
|
| Mar 25, 2002 |
EyeforPharma.com: SciTegic launches Pipeline Pilot version 2.0 for drug discovery informatics research |
|
|
| Mar 22, 2002 |
CNN: Clues for allergies, colds nothing to sneeze at |
|
|
| Mar 20, 2002 |
EyeforPharma.com: Lilly achieves milestone in completion of Internet-based clinical study on experimental treatment |
|
|
| Mar 19, 2002 |
EyeforPharma.com: RxCentric: Busy physicians turning to e-detailing |
|
|
| Mar 18, 2002 |
CNN Money: Turnaround play: Merck |
|
|
| Mar 15, 2002 |
CNN Money: Merck shares tumble |
|
|
| Mar 15, 2002 |
Washington Business Journal: Bioscience law sprouts up as hot field for attorneys |
|
|
| Mar 14, 2002 |
CNN Money: Pfizer drug sales probed |
|
|
| Mar 12, 2002 |
CNBC: Schering-Plough still looks cheap |
|
|
| Mar 11, 2002 |
Boston Globe: No boom yet in analysis of drug data |
|
|
| Mar 11, 2002 |
Business Week: UBS Warburg Downgrades Teva Pharmaceutical |
|
|
| Mar 8, 2002 |
Raleigh/Durham Business Journal: Future of drug firm may hinge on trial |
|
|
| Mar 4, 2002 |
CNN Money: A glance at GlaxoSmithKline |
|
|
| Mar 1, 2002 |
East Bay Business Times: Ciphergen enters China's biotech market |
|
|
| Mar 1, 2002 |
Memphis Business Journal: New FDA charge could trip up biotech ventures |
|
|
| Mar 1, 2002 |
Puget Sound Business Journal: Doctors and biotechs are at odds on drug bill |
|
|
| Mar 1, 2002 |
San Francisco Business Times: Bay Area still dominant, but SoCal growing fast |
|
|
| Mar 1, 2002 |
Atlanta Business Journal: Chamber pushing to grow biotech |
|
|
| Mar 1, 2002 |
Austin Business Journal: Biotech incubator born |
|
|
| Mar 1, 2002 |
Business Courier (Cincinnati): Genome research hub to grow in Reading |
|
|
| Mar 1, 2002 |
Philadelphia Business Journal: At odds: Biotech, Pharma |
|
|
| Feb 28, 2002 |
CNN Money: Roche not talking to Genta |
|
|
| Feb 26, 2002 |
EyeforPharma.com: Knowledge Management at Pfizer: starting from the inside out |
|
|
| Feb 25, 2002 |
CNN Money: FDA widens ICN laser use |
|
|
| Feb 22, 2002 |
CNN Money: Genta drug deal very close |
|
|
| Feb 22, 2002 |
CNN Money: OSI avoids ImClone track |
|
|
| Feb 21, 2002 |
CNN Money: New use for Viagra rival? |
|
|
| Feb 20, 2002 |
CNN Money: Changes in Big Pharma |
|
|
| Feb 20, 2002 |
CNN Money: Exubera in late '02? |
|
|
| Feb 20, 2002 |
Infoworld: IBM recruits allies for life sciences push |
|
|
| Feb 17, 2002 |
San Francisco Business Journal: Hatching a biotech egg |
|
|
| Feb 17, 2002 |
San Francisco Business Journal: Tiny Fluidigm links its pipes to GlaxoSmithKline |
|
|
| Feb 17, 2002 |
Raleigh/Durham Business Journal: Firms lose control by outsourcing |
|
|
| Feb 15, 2002 |
CNN Money: Icahn's ImClone interest |
|
|
| Feb 15, 2002 |
Atlanta Business Chronicle: Geography helped draw millions to Inhibitex |
|
|
| Feb 15, 2002 |
Dallas Business Journal: Biotech report: Come together, right now |
|
|
| Feb 15, 2002 |
Boston Business Journal: Cambridge's heady biotech growth may soon be over |
|
|
| Feb 12, 2002 |
US News & World Report: Career outlook: Ph.D.'s; A brilliant century for biologists |
|
|
| Feb 12, 2002 |
US News & World Report: Career outlook: Health and medicine |
|
|
| Feb 5, 2002 |
Science Magazine: Focus on Careers: Bioinformatics Science |
|
|
| Feb 4, 2002 |
Fortune: Make a Career Switch |
|
|
| Feb 4, 2002 |
Fortune: Finding the Bulls in Biotech |
|
|
| Feb 4, 2002 |
Forbes: Viagra for the Brain |
|
|
| Feb 2, 2002 |
CNN Money: Cheaper drugs needed |
|
|
| Jan 29, 2002 |
MSNBC: Drug industry pipelines drying up |
|
|
| Jan 29, 2002 |
CNN Money: Gruntal likes generic drugmaker's aggressive pursuit of brand-name drugs. |
|
|
| Jan 29, 2002 |
Forbes: Merck Decides To Go It Alone |
|
|
| Jan 28, 2002 |
Forbes: Bristol's Bad FDA Record A Prelude To ImClone |
|
|
| Jan 26, 2002 |
MSNBC: FDA drug approval time speeds up slightly |
|
|
| Jan 25, 2002 |
Nando Times: Outlook for Bristol-Myers Squibb appears murky |
|
|
| Jan 25, 2002 |
Eyeforpharma.com: InforMax and TissueInformatics form informatics and toxicogenomics collaboration |
|
|
| Jan 25, 2002 |
CNNfn: Red flags at ImClone |
|
|
| Jan 25, 2002 |
Forbes: Venter's Gone; Celera's Still Strong |
|
|
| Jan 25, 2002 |
Business Week: Big Trouble in Biotech City? |
|
|
| Jan 25, 2002 |
Eyeforpharma.com: GSK considers selling research units |
|
|
| Jan 23, 2002 |
CNN Money: Strong sales for biotechs |
|
|
| Jan 21, 2002 |
CNN: Michigan program designed to cut drug costs |
|
|
| Jan 21, 2002 |
Eyeforpharma.com: Bioinformatics market to reach $1.7 billion by 2006 |
|
|
| Jan 19, 2002 |
Washington Post: Drug Firms Still Lavish Pricey Gifts On Doctors |
|
|
| Jan 18, 2002 |
Forbes: Special Report: Drug Companies Target AIDS |
|
|
| Jan 18, 2002 |
Los Angeles Times: Nevada Sues Major Drug Firms |
|
|
| Jan 18, 2002 |
New York Times: Merck Is Said to Limit Perks in Marketing to Physicians |
|
|
| Jan 16, 2002 |
Washington Post: Pfizer Offers Discounted Drugs to Low-Income Senior Citizens |
|
|
| Jan 16, 2002 |
TheStreet.com: Cubist Pharmaceuticals Says Drug Flunked Geography Test |
|
|
| Jan 16, 2002 |
USA Today: Australian government may subsidize Viagra |
|
|
| Jan 16, 2002 |
Seattle Post Intelligencer: Immunex awaits FDA word on expanded use for Enbrel |
|
|
| Jan 16, 2002 |
Boston Globe: A drug maker weighs the costs |
|
|
| Jan 16, 2002 |
Financial Times: Biocompatibles jumps on bid rumour |
|
|
| Jan 16, 2002 |
TheStreet.com: Abbott Labs Reports Revenue Rising but Profit Falling |
|
|
| Jan 15, 2002 |
Seattle Times: FDA slaps Icos over premature drug hype |
|
|
| Jan 15, 2002 |
New York Times: At Schering, Optimism and Problems |
|
|
| Jan 14, 2002 |
The Seattle Times: Biotech careers for nonscientists |
|
|
| Jan 14, 2002 |
Business Standard: Bio-informatics, pharma seen as IT engines |
|
|
| Jan 13, 2002 |
Health-e: Drug companies under fire for lack of interest in microbicides |
|
|
| Jan 12, 2002 |
National Post: Pfizer set to launch new ad blitz for Viagra |
|
|
| Jan 11, 2002 |
Dallas Business Journal: Retail slump cools market for pharmacists |
|
|
| Jan 11, 2002 |
The Motley Fool: Outlook For Drug Companies in 2002 |
|
|
| Jan 11, 2002 |
Jerusalem Post: Teva possible buyer for IVAX |
|
|
| Jan 11, 2002 |
Washington Post: AHP gets final OK on fen-phen deal |
|
|
| Jan 11, 2002 |
Chicago Tribune: AHP gets final OK on fen-phen deal |
|
|
| Jan 10, 2002 |
CNNfn: Geron in stem cell pact |
|
|
| Jan 10, 2002 |
msNBC: Roche must pay IGEN $505 million |
|
|
| Jan 10, 2002 |
The Daily Deal: Teva seen pursuing Ivax |
|
|
| Jan 10, 2002 |
Seattle Times: New setback from FDA for Corixa drug |
|
|
| Jan 10, 2002 |
CNET/Reuters: Genentech, City of Hope retrial delayed to March |
|
|
| Jan 10, 2002 |
Ananova: Roche to appeal US ruling awarding IGEN $505 million damages in license suit |
|
|
| Jan 10, 2002 |
National Post: Biovail faces inquiry by U.S. officials |
|
|
| Jan 10, 2002 |
BBC News: Viagra web doctor suspended |
|
|
| Jan 9, 2002 |
CNNfn: ImClone may need new trials |
|
|
| Jan 9, 2002 |
TheStreet.com: Corixa's Cancer Drug Misses the FDA Panel Again |
|
|
| Jan 9, 2002 |
Philly.com: Merck cited by FDA for violations |
|
|
| Jan 9, 2002 |
USA Today: Head of Bayer's pharmaceutical unit replaced |
|
|
| Jan 9, 2002 |
Ananova: Pfizer receives US Congress subpoena seeking drug price data - report |
|
|
| Jan 8, 2002 |
CNNfn: Genzyme General upbeat on 2002 |
|
|
| Jan 8, 2002 |
National Post: Procyon Biopharma rides crest of Biovail wave |
|
|
| Jan 8, 2002 |
EyeforPharma.com: Gene Logic and Compugen partner to expand genomic content offering |
|
|
| Jan 8, 2002 |
CNNfn: Genentech, Biogen see growth |
|
|
| Jan 8, 2002 |
iWon/Reuters: FTC probes patent listings filed by drug firms |
|
|
| Jan 8, 2002 |
Gene Therapy: Exonhit Therapeutics and Idec Pharmaceuticals Annouce Collaborative Agreement in Target Discovery |
|
|
| Jan 8, 2002 |
CNET/Reuters: Genentech sees no new drugs in 2002, six in 2003 |
|
|
| Jan 8, 2002 |
iWon/Reuters: Former pharma CEO Leschly aims for top |
|
|
| Jan 8, 2002 |
Washington Post: Drug Firms Fight Prescription Plan |
|
|
| Jan 8, 2002 |
Financial Times: SkyePharma reaches across Atlantic |
|
|
| Jan 8, 2002 |
Chicago Tribune: Earnings predictions a pain for Merck investors |
|
|
| Jan 8, 2002 |
Hugin Online: Atugen Announces Collaboration with Novo Nordisk |
|
|
| Jan 8, 2002 |
Media Week: OMD Awarded Eli Lilly $80 million Media Account |
|
|
| Jan 8, 2002 |
Business Week: CS First Boston Upgrades Teva Pharmaceutical |
|
|
| Jan 8, 2002 |
Bioportfolio.com: GAO Study Presents Opportunity for Pharmaceutical Companies |
|
|
| Jan 7, 2002 |
Chemical & Engineering News: Careers in Bioinformatics |
|
|
| Jan 7, 2002 |
Atlas Venture: Exelixis and Schering-Plough Collaborate on Customized Compound Library |
|
|
| Jan 7, 2002 |
Ananova: Bristol-Myers lower on report of problems with ImClone's Erbitux |
|
|
| Jan 7, 2002 |
The Independent: SkyePharma risk is worth taking |
|
|
| Jan 7, 2002 |
iWon/Reuters: New data may speed sales of Novartis's Glivec |
|
|
| Jan 7, 2002 |
iWon/Reuters: Chiron to buy Matrix Pharmaceutical for $61 million |
|
|
| Jan 5, 2002 |
Business Standard: Intas to acquire ICI pharma business for Rs 70 crore |
|
|
| Jan 5, 2002 |
Ananova: "Date-rape" drug firms may be sued |
|
|
| Jan 5, 2002 |
TheStreet.com: Chiron Mum as 2001 Passes Without Blood Test Approval |
|
|
| Jan 5, 2002 |
National Post: Biovail to sell drug in U.S. |
|
|
| Jan 4, 2002 |
Ananova: AstraZeneca shares fall in knee-jerk reaction to patent decision |
|
|
| Jan 4, 2002 |
Miami Herald: Drug firms lose fight; state's `preferred' list ruled lawful |
|
|
| Jan 4, 2002 |
Boston Herald: Drug firm sued for alleged overcharges |
|
|
| Jan 4, 2002 |
New York Daily News: Merck, Schering
Tackle Cholesterol |
|
|
| Jan 4, 2002 |
iWon/Reuters: INTERVIEW-Taisho Pharmaceutical values its independence |
|
|
| Jan 3, 2002 |
CNNfn: Will pig clones save biotechs bacon? |
|
|
| Jan 3, 2002 |
USA Today: Anti-colorectal cancer drug faces FDA obstacle |
|
|
| Jan 3, 2002 |
iWon/Reuters: Astra Zeneca yields exclusivity on Prilosec patent |
|
|
| Jan 3, 2002 |
ABC News: What's Next After Viagra? |
|
|
| Jan 3, 2002 |
Washington Post: Low Fliers Behind the Drugs |
|
|
| Jan 2, 2002 |
Gene Therapy: Genome Therapeutics Announces Extension of Asthma Genomics Alliance With Schering-Plough |
|
|
| Jan 2, 2002 |
The Daily Deal: Drug maker first to file for IPO in 2002 |
|
|
| Jan 2, 2002 |
iWon/Reuters: Teva gets tentative U.S. nod for Cipro generics |
|
|
| Jan 2, 2002 |
iWon/Reuters: Schering, Merck Drug Shows No Improvement |
|
|
Print
This Page
